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DIFFERENTIAL ACCUMULATION OF STORAGE BODIES WITH AGING DEFINES 
DISCRETE SUBSETS OF MICROGLIA IN THE HEALTHY BRAIN 
 
JEREMY CARLOS BURNS 
Boston University School of Medicine, 2021 




 Microglia are a unique type of immune cell found within the brain, spinal cord 
and retina. In the healthy brain, their job is to support neurons, defend against 
infectious microbes, clear extracellular debris and remove dead or dying cells 
through phagocytosis. This diverse array of functions presents the possibility of 
unique subsets of microglia existing in the healthy brain, yet none have been 
described thus far. By utilizing cellular autofluorescence as a discriminating 
characteristic, we identified two novel subsets of microglia present in the healthy 
brains of mice and non-human primates. Approximately 70% of microglia displayed 
autofluorescence (AF+) while the remaining 30% did not (AF–). While the proportion 
of AF+ and AF– microglia remained constant throughout most of adult life, the 
autofluorescence intensity increased exclusively in the AF+ subset at an almost linear 
rate with age. This gain in autofluorescence correlated with equivalent increases in 
the size and complexity of storage bodies, as detected by transmission electron 





compartment. As the brain ages, lysosomal storage material builds up inside AF+ 
microglia, further increasing the accumulation of autofluorescence as a result. The 
analysis of protein content in autofluorescent subsets revealed that AF+ microglia 
produced more proteins and enzymes involved in the storage and degradation of 
waste material, as well as more proteins involved in the regulation of mTOR, a key 
cellular pathway governing nutrient availability and energy production. Interestingly, 
the disruption of lysosomal function in microglia through genetic mutations 
accelerated the accumulation of storage material in AF+ cells, which led to impaired 
microglia physiology and increased cell death, mimicking the effects observed during 
advanced aging. Increasing evidence suggests that the accumulation of waste 
materials inside the brain contributes to diseases of aging and these data are 
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CHAPTER ONE: INTRODUCTION 
In the US and most of the developed world, dementias such as Alzheimer’s Disease 
(AD), vascular dementia and Parkinson’s Disease (PD) are top contributing factors to 
mortality rates. AD, the most prevalent dementia in the US, affects an estimated 5.8 
million individuals over the age of 65 (Alzheimer’s Association, 2020). A number of 
genetic and modifiable risk factors of dementia have been identified, however, their 
individual weight towards disease risk is low. As the risk of AD doubles every five 
years after age 65, aging represents the single largest risk factor for AD and for most 
late-onset dementias (Alzheimer’s Association, 2020).  
There is increasing genetic and preclinical evidence for the role of glial cells in 
neurocognitive disease, but the precise molecular mechanisms precipitating the 
onset and progression of AD and related dementias continue to be debated. Microglia, 
which are a unique population of tissue resident macrophages residing in the central 
nervous system (CNS), account for 10% to 15% of all cells within the CNS. Of the 
approximately 30 AD risk genes and variants identified in GWAS and NGS studies thus 
far, the majority are known to be expressed in microglia, typically at higher levels 
relative to other resident CNS (e.g. ABCA7, APOE, BIN1, CD33, CR1, GRN, IL1RAP, 
PICALM, SORL1, SPI1 and TREM2), strongly implicating this glial cell type in AD 
pathogenesis (Figure 1) (Cuyvers & Sleegers, 2016; Takatori et al., 2019). In addition, 
the known molecular activities of identified risk genes associate with key pathways 




CD2AP), lipid metabolism (APOE, CLU, and ABCA7), and inflammation (TREM2, CD33, 
CR1, PLCG2, and INPP5D) (Cuyvers & Sleegers, 2016; Takatori et al., 2019). 
Continuing to explore the role of microglial cellular functions in the context of 
homeostasis and in aging is likely to yield insights into the pathological mechanisms 
behind age-associated neurodegenerative diseases.  
 
Figure 1. Timeline of genes identified as risk factors in AD.  
* denotes genes mapped to microglial function. Adapted from (Cuyvers & Sleegers, 2016) and 
(Pimenova, Raj & Goate, 2018).  
 
Ontogenic origin and role in CNS development 
Despite displaying some canonical macrophage activities, such as the 
phagocytosis of debris and apoptotic bodies (Chan et al., 2001; Janda et al., 2018), the 
ontogenic origins of microglia are distinct from that of peripheral macrophage 
populations. Through a series of well-controlled fate mapping studies and parabiosis 
experiments, a significant body of evidence has determined that an initial wave of 




resident macrophages such as Kupffer cells, Langerhans cells, alveolar macrophages 
and renal macrophages (Figure 2) (Gomez Perdiguero et al., 2015).  
 
Figure 2. Ontogeny and development of microglia and tissue macrophages.  
Adapted from (Li & Barres, 2017). 
 
In utero, yolk sac CX3CR1+ primitive macrophages develop and transit through 
the vasculature into the CNS, where migration peaks at E10.5 and subsides by E12.5, 




coincidence, the kinetics of yolk sac macrophage migration is regulated 
independently of fetal liver hematopoiesis, as trafficking of yolk sac CX3CR1+ cells was 
unaffected in mice lacking the key hematopoietic transcription factor MYB (Stremmel 
et al., 2018). The onset of fetal liver hematopoiesis generates monocytes and 
granulocytes, which contribute to the resident macrophage population in peripheral 
tissues, mainly the intestines and lungs, and coincides with the emergence of the 
blood-brain barrier (BBB) at E14.5 (Gomez Perdiguero et al., 2015). While fetal liver-
derived tissue macrophages are generally indiscernible from resident yolk sac-
derived macrophages, it is believed that the newly formed BBB blocks the migration 
of fetal liver monocytes into the brain parenchyma and prevents dilution of the 
original yolk sac-derived microglial population. 
Following embryonic development, microglia undergo a coordinated shift in 
transcriptional program through significant reorganization of the chromatin 
landscape (Matcovitch-Natan et al., 2016). Several studies have now shown that this 
fetal-to-postnatal transition is partially dependent on the microbiome, as microglia 
isolated from germ-free mice do not upregulate key microglia genes (Cst7, Relb, 
Cxcl10) and exhibit an under-developed phenotype (Erny et al., 2015; Matcovitch-
Natan et al., 2016; Thion et al., 2018; Pasciuto et al., 2020). Microglia maturation is 
also dependent on the presence of CNS-resident T cells, as CD4+ T cell-deficient MHC 
II knockout mice failed to upregulate key microglia maturation transcription factors 
(Fos, Jun, Klf4 and Egr1) and displayed increased synaptic spine density along with 




cells require initial activation in the gut, as fewer T cells were observed in the brains 
of germ-free mice, potentially providing a link between the microbiome and 
microglial maturation (Pasciuto et al., 2020).  
In addition to the transcriptional reprogramming of the fetal microglia 
population, a transient CD11C+ microglia subset emerges during late embryogenesis 
and persists through the first postnatal week in mice. These CD11C+ cells localize to 
white matter tracts of the mouse brain and evidence suggests that this population is 
essential for proper oligodendrocyte homeostasis and myelinogenesis during post-
natal development (Wlodarczyk et al., 2017; Hagemeyer et al., 2017). Recently 
dubbed proliferative-region-associated microglia (PAM), this microglia subset shares 
a large degree of transcriptional similarity to microglia which emerge during aging or 
in disease models ((Keren-Shaul et al., 2017; Krasemann et al., 2017), as scRNAseq 
identified elevated expression Clec7a, Itgax, Lilrb4, Gpnmb (Li et al., 2019). 
Interestingly, the emergence of PAM occurred independently of TREM2 or APOE, in 
contrast microglia observed in aging and disease (Li et al., 2019). It is hypothesized 
that the CD11C+ PAM present during early development are closely related to the 
lipid-laden amoeboid cells present within the “fountains of microglia”, originally 
described by Rio-Hortega, and which transiently appear in early developing white 
matter across multiple species, including late-stage human embryos (Menassa & 
Gómez-Nicola, 2018). The emergence of PAM coincides with the onset of myelination, 
which peak at P5 and disappear by P15 in mice and is associated with 




phagocytic in vitro, PAM were also observed to phagocytose newly formed 
oligodendrocytes in situ (Hagemeyer et al., 2017; Li et al., 2019). Further implicating 
their role in myelination, white matter associated CD11C+ microglia are a major 
source of IGF1 in the developing CNS and the conditional deletion of Igf1 in CD11C+ 
cells resulted in lower brain weight, decreased expression of genes involved in 
myelinogenesis (Plp, Mag and Mbp) and increased G-ratios (Wlodarczyk et al., 2017). 
In addition to Igf1, microglia may further contribute to neuronal development 
through the expression of axonal guidance signals Cxcl12, Ntn1, Plxna2 and Sema7a 
(Wlodarczyk et al., 2017).   
Functions of microglia during homeostasis 
The murine postnatal core homeostatic transcriptional signature, negligibly 
expressed in macrophages and therefore unique to microglia, shares significant 
overlap with humans and includes Sall1, Hexb, Fcrls, Gpr43, Cx3cr1, Tmem119, Trem2, 
P2ry12, Mertk, Pros1 and SiglecH (Dubbelaar et al., 2018). The complete transition 
from fetal to adult stage homeostatic microglia is correlated with increased 
expression of transcriptional regulators Sall1, Fos, Mafb, Mef2a and Jun and the 
downregulation of E2f6 and Dnmt1 (Matcovitch-Natan et al., 2016). In particular, 
transcriptional regulation by MAFB is critical for maintaining homeostasis in adult 
microglia, as lineage specific deletion led to upregulation of interferon responsive 
genes (Oas2, Mxl, Ifit3, Cxcl10 and Il1b), phagocytosis/lysosomal genes (Ctsh, Axl, C2) 




In addition to MAFB, TGF-β, which has been shown to maintain tissue resident 
macrophage identity in the periphery, is also responsible for maintaining a robust 
portion of the microglial homeostatic signature in vivo, as deletion of Tgfb1 results in 
the loss of detectable microglia in murine brains (Butovsky et al., 2013; Gosselin et 
al., 2014). CSFR1 signaling is also key to microglia survival, as mice deficient in Csf1r 
have no detectable microglia as of 3 weeks of age. CSF1R has two ligands which are 
expressed in the brain: CSF1, which is expressed by astrocytes and oligodendrocytes 
and IL-34, which is expressed by neurons. Interestingly, deletion of either ligand in 
mice results in diminished numbers of microglia, but with regional differences, as 
white matter microglia appear to be dependent on CSF1 whereas gray matter 
microglia require IL-34 for survival (Easley-Neal et al., 2019). However, only CSF1 is 
required for prenatal microglia development and colonization of the brain (Easley-
Neal et al., 2019).  
Similar to peripheral tissue resident macrophages, microglia are long lived 
and undergo low rates of proliferation, with an average age of 4.2 years and a median 
replacement rate of 28% per year in humans (Réu et al., 2017). Throughout life, the 
number of microglial cells remains remarkably steady in both mice and humans, 
without a noticeable contribution from circulating monocytes (Askew et al., 2017). 
The turnover of microglia in adult mice is similarly limited and is estimated to occur 
at a rate of under 1% per day with a median lifespan of approximately 15 months 
(Lawson, Perry & Gordon, 1992; Askew et al., 2017; Tay et al., 2017; Füger et al., 




reactive proliferation were solely limited to resident microglia, and that infiltrating 
peripheral monocytes did not contribute to cellular turnover (Ajami et al., 2007). 
After ablation by CSF1R inhibition, the repopulation of microglia occurs via the 
proximal clonal expansion of surviving microglia, forming spatial clusters with 
limited cell migration (Zhan et al., 2019). Proliferative self-renewal was observed to 
be spatially and temporally coupled to the apoptosis of nearby microglia as inhibition 
of microglia apoptosis resulted in an increased accumulation of Iba1+ microglia 
within the brain (Tay et al., 2017; Askew et al., 2017). Inversely, microglia specific 
deletion of Il1r1 resulted significantly lower microglia cell numbers, indicating a role 
for IL1α-IL1Rα signaling in maintenance of microglial cellular density (Bruttger et al., 
2015).  
During homeostasis and in the absence of injury, microglia chemotaxis is 
minimal, however, their individual processes are highly motile and engaged in 
constant surveillance through frequent contact with neighboring synaptic elements 
(Nimmerjahn, Kirchhoff & Helmchen, 2005). Microglial process surveillance is known 
to be dependent on the degree of local neuronal activity, as sensory deprivation by 
whisker trimming (Wake et al., 2009), dark-rearing (Tremblay, Lowery & Majewska, 
2010) and GABAA-mediated neuronal inhibition increased process motility and 
synaptic contact (Wake et al., 2009; Liu et al., 2019). This highly dynamic morphology 
has been known to be modulated (both positively and negatively) via a combination 
of chemokine (e.g. CX3CR1), purinergic (e.g. P2Y12, P2X7), adrenergic (β2 and α2A) 




2016). Microglia are therefore uniquely poised to detect and respond to changes in 
neighboring neuronal activity.  
Throughout life, neural circuits exhibit plasticity based on experience, 
executing structural changes in synaptic connectivity in response to alterations in 
activity. Increasing evidence supports microglia as key regulators of synaptic 
formation and stabilization (Kaneko et al., 2008; Parkhurst et al., 2013; Miyamoto et 
al., 2016). Recently, it was demonstrated that microglia promote fear memory 
formation through remodeling of the extracellular matrix in an IL-33 dependent 
manner (Nguyen et al., 2020). Loss of IL-33 or IL-33R on neurons or microglia, 
respectively, led to decreased dendritic spine formation, decreased newborn neuron 
integration and decreased precision of remote fear memories (Nguyen et al., 2020). 
Interestingly, IL-33 expression is decreased in aged mice and correlated with 
decreases in spine plasticity, a phenomenon that could be rescued by IL-33 gain-of-
function (Nguyen et al., 2020).  
Another functional consequence of the frequent surveillance and contact with 
synaptic components is remodeling of neuronal circuits via phagocytosis. Recent 
findings have linked microglia surveillance to dendritic spine dynamics and deficits 
in microglia motility are speculated to contribute to abnormalities in synaptic density 
associated with specific neurodevelopmental disorders (Paolicelli et al., 2011). At 
steady state, microglia contribute to synaptic maturation through the phagocytic 
reduction of supernumerary synaptic connections (Tremblay, Lowery & Majewska, 




highlighted in studies with Cx3cr1-KO mice, resulted in the defective maturation of 
cortical glutamatergic synapses during development and the failure to remove 
synapses in the mouse barrel cortex following whisker lesioning (Basilico et al., 2018; 
Gunner et al., 2019). A key signaling pathway involved in synaptic remodeling is the 
complement cascade and involves C1q, C3, C4 and the receptor CR3 (Itgam) (Stevens 
et al., 2007; Schafer et al., 2012). The deletion of C1q in mice (C1qa –/–) results in 
spontaneous absence seizures, induced by excessive synaptic connectivity from lack 
of pruning during development (Chu et al., 2010) and the microglia-specific deletion 
of the CR3 receptor reduced the frequency of phagocytic inclusions of presynaptic 
terminals observed within microglia (Schafer et al., 2012). Recent GWAS and family-
based association studies have linked structural polymorphisms in C4 genes to 
schizophrenia, suggesting that defective synaptic pruning by microglia may underlay 
some instances of this neuropsychiatric disorder (reviewed (Woo et al., 2020)) and 
highlights the role of microglia and innate immunity in the maintenance of neuronal 
networks. 
In addition to synaptic pruning, the phagocytic elimination of defective or 
senescent cells undergoing apoptosis is a central mechanism in the maintenance of 
tissue homeostasis and organismal function. The phagocytosis of apoptotic cells is 
coordinated through a conserved and redundant set of secreted “find-me” and 
membrane-bound “eat-me” signals recognized by professional phagocytes, such as 
microglia. Microglia express high levels of metabotropic purinergic P2Y receptors 




Once in contact with the apoptotic cell, a number of possible “eat-me” signals can 
signal to microglia to trigger phagocytosis. Phosphatidylserine (PS), a plasma 
membrane lipid exposed during apoptosis, will engage a number of surface molecules 
on phagocytes, including TIM4, GAS6, Protein S and the TAM (TYRO3, AXL, MERTK) 
receptor family. Triggering receptor expressed by myeloid cells-2 (TREM2) and 
CD300B also participate in the clearance of apoptotic cells, along with the beta glucan 
receptor CLEC7A, which has been linked to the phagocytosis of oligodendrocytes 
(Hsieh et al., 2009; Takahashi, Rochford & Neumann, 2005; Li et al., 2019). TREM2 is 
an immunoglobulin-like surface receptor expressed on macrophages, dendritic cells 
and microglia and associates with the immunoreceptor tyrosine-based activation 
motif (ITAM) signaling molecule DAP12. Knockdown or deletion of TREM2 in 
microglia led to decreased phagocytosis of apoptotic neurons and increased 
expression of pro-inflammatory molecules Tnfa and Nox2 (Takahashi, Rochford & 
Neumann, 2005; Kleinberger et al., 2014). iPSC-derived microglia-like cells carrying 
the TREM2 missense mutations linked to Nasu-Hakola disease exhibited specific 
impairments in the phagocytosis of apoptotic bodies, but not bacterial or zymosan 
substrates (Garcia-Reitboeck et al., 2018). While Trem2–/– microglia exhibited no 
defects in the uptake of myelin, these cells failed to upregulate lipid metabolism genes 
in response to phagocytosis and accumulated cholesteryl esters in a manner similar 
to Apoe-/- microglia (Nugent et al., 2020). Through phagocytosis, microglia maintain a 
healthy steady-state environment through the efficient clearance of neighboring 




This diversity in functions would suggest the possibility of microglia 
heterogeneity, and while transcriptomic heterogeneity has been observed in the 
steady-state adult CNS, discrete subsets with characterized cellular functions have yet 
to be clearly elucidated. Hints of microglial heterogeneity were first reported as 
regional variations in cellular density throughout the brain (Lawson et al., 1990). 
More recently, heterogeneity in gene expression profiles of regionally isolated 
microglia were reported, pointing to region-specific microglia functions and possibly 
subsets in healthy brain (Ayata et al., 2018; Grabert et al., 2016). Through the gene 
expression analysis of regionally isolated young adult murine microglia, it was 
observed that cerebellar microglia were the most distinct, that cortical and striatal 
microglia were relatively similar to each other, and that hippocampal microglia 
exhibited an intermediate profile (Grabert et al., 2016). Genes associated with the 
regulation of energy production were upregulated in cerebellum and hippocampus, 
which were suggestive of differences in the metabolic demand of microglia residing 
in these regions (Grabert et al., 2016). Transcriptomic analysis also revealed that 
cerebellar microglia generally expressed higher levels of ITAM-containing or -
associating receptors whereas cortical microglia expressed higher levels of inhibitory 
ITIM receptors, possibly indicating differences in phagocytic functions by region 
(Grabert et al., 2016). Cerebellar microglia were also enriched in mRNAs encoding 
proteins associated with clearance functions, such as APOE, AXL, CD74, LILRB4 and 
MS4A7 (Ayata et al., 2018). Higher protein expression of the endolysosomal marker 




of DAPI+ material detected within lysosomes, further supporting differences in 
phagocytosis by region (Ayata et al., 2018). Interestingly, this regional transcriptional 
heterogeneity was determined to be epigenetically regulated via PRC2 H3K27 
methylation, as PRC2-deficiency resulted in the loss of regionally specified microglia 
gene expression and clearance functions (Ayata et al., 2018). Despite these regional 
transcriptomic differences, no identifiable microglia subsets have emerged from 
these findings.  
Role of and regulation of lysosomal processing in microglia  
A considerable volume of ingested material is delivered via phagosomes to the 
lysosomal compartment for degradation and recycling, as a significant portion of 
microglia activity revolves around the clearance of synaptic elements, apoptotic 
neurons, extracellular deposits and damaged myelin. While myelin is quite 
metabolically stable, with a half-life of in the range of weeks to months, degradation 
does occur and myelin fragments are shed into the extracellular space where they are 
cleared by microglia (Toyama et al., 2013; Safaiyan et al., 2016). Despite its relative 
stability, the slow turnover of myelin, which accounts for ~30% of the dry weight of 
the brain, would still generate a large amount of lipid-based debris requiring 
clearance and lysosomal degradation by microglia over an individual’s lifetime 
(Schmitt, Castelvetri & Simons, 2015).  
Since their discovery and characterization more than 65 years ago (de Duve et 




in the cell and are involved in a diverse myriad of cellular processes which include 
cholesterol trafficking, nutrient sensing, transcriptional regulation, metal ion 
homeostasis and inflammatory responses (Figure 3). As the terminal degradative 
organelle for macroautophagy and phagocytosis, lysosomes breakdown a wide array 
of material that includes macromolecules, aggregated proteins, apoptotic cell debris 
and damaged organelles. In order to properly disassemble complex components into 
their constituent base molecules, lysosomes contain an array of approximately 60 
catabolic enzymes (proteases, lipases, nucleases), most of which require an acidic pH 
optimum to be maintained by the H+ proton pump v-ATPase (Perera & Zoncu, 2016).  
 
 





Adapted from (Saftig & Klumperman, 2009).  
 
Under homeostatic conditions, the lysosome is a highly adaptive system 
capable of sensing the nutritional state of the cell as well as responding to changes in 
metabolic demands. Lysosomal biogenesis and function are controlled by 
transcription factor EB (TFEB), identified as the key transcriptional regulator 
governing these processes (Sardiello et al., 2009). Through nuclear translocation, 
TFEB supports lysosomal biogenesis by binding to promoter regions containing 
“coordinated lysosomal expression and regulation” (CLEAR) motifs, resulting in the 
upregulation of key lysosomal genes and enzymes (Sardiello et al., 2009). The 
subcellular localization of TFEB is tightly controlled through the post-translational 
modification of a number of conserved amino acid residues by a set of kinases and 
phosphatases. The phosphorylation of TFEB by the serine-threonine kinases 
mechanistic target of rapamycin complex 1 (mTORC1), mitogen activated kinase 1 
(MAPK1), protein kinase b (Akt), glycogen synthase kinase 3b block translocation of 
TFEB into the nucleus and promote its cytosolic sequestration. While TFEB activity is 
negatively regulated by mTORC1, lysosomes are themselves key regulators of 
mTORC1 activity (Liu & Sabatini, 2020). Through the amino acid-sensing 
multimolecular Rag-Ragulator complex assembled on the lysosome, mTORC1 is 
recruited from the cytosol to the lysosomal surface, where it is brought in proximity 
to and activated by the small GTPase Rheb (reviewed (Liu & Sabatini, 2020)). The 




restore its ability to enter the nucleus and initiate transcriptional activation of CLEAR 
genes.  
In microglia, the expression and activation of TFEB facilitated fibrillar Aβ 
degradation and reduced deposited amyloid plaques in ex vivo APP/PS1 brain slices 
(Bao et al., 2016). Given the central role of TFEB in regulating lysosomal function, it 
presents as an attractive pharmacological target for a number of disorders for which 
restoring lysosomal capacity is hypothesized to provide therapeutic benefit.  
Interestingly, even though mTORC1 is known to inhibit TFEB, recent in vivo studies 
with Tsc1-deficient microglia demonstrated that elevated mTOR signaling leads to 
robust phagocytosis activity and enhanced lysosomal function in mice (Zhao et al., 
2018). 
Lysosomal dysfunction underlies many neurological diseases 
Evidence for the central importance of lysosomes to the maintenance of 
cellular homeostasis can be found in the fact that over 50 hereditary disorders have 
been classified as lysosomal storage diseases (LSDs) (Boustany, 2013). Interestingly, 
the majority of LSDs exhibit some degree of neurologic involvement, of which a subset 
manifest exclusively within the nervous system. A particular hallmark common to 
most neurological LSDs is neuroinflammation accompanied by robust microgliosis. 
However, it is still a matter of debate as to whether microglia are initiating the 
associated pathology or bystanders reacting to neuronal dysfunction and further 




Neuronal ceroid lipofuscinoses (NCL) are a family of inherited, fatal 
neurodegenerative disorders generally characterized by lysosomal dysfunction, 
protein aggregation and lipofuscin accumulation. The most common juvenile form of 
NCL has been linked to a 1kb deletion of exons 7/8 of CLN3, which is involved in the 
regulation of lysosomal pH, cathepsin activity, and endocytic trafficking, (Cárcel-
Trullols, Kovács & Pearce, 2017; Cotman et al., 2002; Golabek et al., 2000; Schmidtke 
et al., 2019). This specific mutation in CLN3, resulting in a premature stop codon and 
loss of the lysosomal targeting sequence, is associated with lysosomal accumulation 
of protein aggregates, particularly the specific buildup of subunit c of mitochondrial 
ATP synthase and of lipofuscin (Kyttälä et al., 2004; Sleat et al., 2016). These 
lysosomal accumulations generate the telltale osmophilic fingerprint deposits that 
are visible by electron microscopy and represent the primary criteria for differential 
diagnoses (Kyttälä et al., 2004; Kominami et al., 1992; Anderson et al., 2006).  
In addition to CLN3, the collection of NCLs have been traced to mutations in 
12 other genes (CLN1-13), including GRN (CLN11), which encodes the growth factor 
progranulin (PGRN) (Cotman et al., 2013). In 2006, mutations of GRN resulting in 
PGRN haploinsufficiency were discovered to cause frontotemporal lobar 
degeneration (FTLD) a clinically heterogenous, incurable neurodegenerative disease 
and the second leading cause of early onset dementia (Cruts et al., 2006; Baker et al., 
2006). Interestingly, carriers of mutations in lysosomal genes are at a much higher 
risk for late-onset neurodegenerative disorders.  Individuals homozygous for 




characterized by progressive vision loss, ataxia and cerebellar atrophy, 
demonstrating a gene-dosage effect for GRN (Almeida et al., 2016). However, while 
single-copy mutations resulting in GRN haploinsufficiency do not cause NCL, these 
variants are major risk factors for FTLD and patients often exhibit NCL-related 
phenotypes. While the homozygous loss of GBA leads to Gaucher disease, a juvenile-
onset lysosomal disorder, genetic variants of GBA have been linked to increased risk 
of Parkinson and Lewy body disease (Aharon-Peretz et al., 2005).  Lastly, mutations 
in NCL-associated genes CTSD and ATP13A2/PARK9 have also been linked to late-
onset Alzheimer’s disease and Parkinson disease, respectively, further suggesting 
that lysosomal dysfunction may be an common mechanism underlying different 
manifestations of neurodegeneration (Ward et al., 2017a; Schuur et al., 2011; Ramirez 
et al., 2006). 
While NCL disease pathology had been primarily attributed to neuronal 
degeneration directly caused by cell-intrinsic lysosomal dysfunction, astrocytes and 
microglia are known to be functionally defective and may be detrimental to neurons 
as well (Parviainen et al., 2017). In Cln3Δex7/8 mice, significant microgliosis was 
observed to occur as early as 5 months of age, preceding the onset of 
neurodegeneration, which was only evident at 14 months of age (Pontikis et al., 
2004). This finding was also reported in Grn-/- mice, as deficits in lysosomal 
cathepsins were observed only in microglia at 3 months of age (Götzl et al., 2018). 
Microglia from Cln3Δex7/8 mice are poised to promote a proinflammatory phenotype, 




activation of the inflammasome and subsequent IL-1β release (Xiong & Kielian, 2013). 
While the pro-inflammatory phenotype of Cln3Δex7/8 microglia was linked to increased 
caspase-1 activity, the deletion of Casp1 in Cln3Δex7/8 mice only partially restored 
motor deficits and without significant differences in microglial activation or 
lysosomal accumulations (Xiong & Kielian, 2013; Burkovetskaya et al., 2018). 
Recently, Centa et al. demonstrated that anti-sense oligonucleotide mediated exon-
skipping could be therapeutically administered via intracranial injection into 
neonatal Cln3Δex7/8 mice, which restored the open reading frame and lysosomal 
targeting of CLN3 protein while reducing motor deficits and markers of 
neuroinflammation observed by histopathology (Centa et al., 2020). However, it was 
not reported as to whether microglia or neuronal cells were predominantly targeted 
by the anti-sense oligonucleotide therapy, leaving open the question as to which cell 
type is propagating pathology.  
Microglia in aging and disease 
There is mounting evidence that aging induces perturbations in microglial 
homeostasis that impact their cellular functions and likely contribute to age-related 
neurodegeneration. Perhaps the most apparent and earliest characterized age-
related change is the physical transformation microglia undergo, progressively 
devolving from a delicately ramified form with fine elongated processes into a 
dystrophic state marked by spheroid swelling and fragmented, stubby processes 




Accompanying this physical transformation is a plethora of transcriptional 
and subcellular changes. Studies utilizing bulk RNAseq analysis of aged human 
microglia revealed altered expression of genes involved in pathways encompassing 
actin assembly, phagocytosis, antigen presentation and telomere maintenance, as 
well as changes to the surface profile of ‘sensome’ receptors (Galatro et al., 2017; Olah 
et al., 2011). Bulk RNAseq studies of murine microglia observed similar 
transcriptional changes with aging, with downregulation and upregulation of 31% 
and 13%, respectively, of the genes comprising the microglia sensome. Interestingly, 
the majority of the downregulated genes encode sensome proteins which detect 
endogenous ligands (P2ry12, P2ry13, P2rx7, Trem2, Siglech) whereas the majority of 
upregulated sensome genes encode proteins directed towards bacterial and fungal 
ligands (Tlr2, Cd74, Ltf, Clec7a, Cxcl16 and Ifitm6) (Hickman et al., 2013). Single-cell 
RNAseq analysis of young and aged murine microglia did not detect an overt 
emergence or dissipation of specific microglia clusters, however, there was a noted 
expansion of existing microglia clusters expressing Ccl3, Ccl4, Il1b and interferon 
induced transmembrane protein 3 (Ifitm3) (Hammond et al., 2019).  
Commensurate with the aging-induced depression of the microglia sensome 
and the loss of resting dendritic morphology, microglial phagocytic capacity is also 
markedly diminished in aged brains, impacting the clearance of myelin (Safaiyan et 
al., 2016), Aβ fibrils (Floden & Combs, 2011; Daria et al., 2017), a-synuclein fibrils 
(Bliederhaeuser et al., 2016) and apoptotic cell bodies (Damisah et al., 2020). Recent 




phagocytosis (Pluvinage et al., 2019). Interestingly, CD22 is significantly upregulated 
in aged microglia and the functional inhibition of CD22 was shown to increase 
microglial phagocytic capacity and restore homeostatic signatures, which correlated 
with improved cognitive function in aged mice (Pluvinage et al., 2019). In addition to 
transcriptional changes, microglia also demonstrate intrinsic subcellular changes, 
such as the accumulation of lysosomal storage bodies containing large amounts of the 
autofluorescent material lipofuscin. The dysfunctional expansion of the lysosomal 
compartment may impede cellular functions, as mutant zebrafish microglia lacking 
the lysosomal transporter Slc37a2 exhibited enlarged lysosomes accompanied by 
decreased motility and phagocytosis in response to UV laser induced CNS injury 
(Villani et al., 2019).  The lysosomal accumulation of sarkosyl-insoluble lipofuscin 
granules is one of the most specific biomarkers for the age of postmitotic or slowly 
dividing cells and in microglia, it has been proposed that the phagocytosis of myelin 
debris is a primary driver of lipofuscin accumulation (Safaiyan et al., 2016). While 
lipofuscin accumulation has been correlated with functional cellular decline, 
mitochondrial defects, oxidative stress and inflammasome activation (Jung, Bader & 
Grune, 2007; Bernhardi, Eugenín-von Bernhardi & Eugenín, 2015; Höhn & Grune, 
2013; Höhn et al., 2011; Gabandé Rodríguez et al., 2018; Cantuti-Castelvetri et al., 
2018), it has not been definitively determined as to whether lipofuscin is the primary 
driver of microglia aging defects in vivo, as it is not currently possible isolate and 
characterize, from the same subject, microglia which contain lipofuscin from those 




In contrast to their diminished homeostatic activities, aged microglia exhibit 
an elevated baseline state of activation and are considered more reactive to 
inflammatory stimuli, particularly TLR ligands, responding with increased levels of 
pro-inflammatory cytokines for longer periods of time post-stimulation. This 
dysregulated inflammatory response, observed in mice, primates, and humans, is 
characterized by increased expression of pro-inflammatory (TNFα, IL-1β, IL-6) and 
anti-inflammatory cytokines (IL-10, TGFβ1) as well as upregulation of MHC-II 
(Shobin et al., 2017; Sloane et al., 1999; Norden & Godbout, 2013; Perry, Matyszak & 
Fearn, 1993). In particular, when the CNS is stimulated via intracerebroventricular 
administration of LPS, aged mice exhibit exaggerated and prolonged sickness 
responses compared to younger controls (Huang et al., 2008; Wynne et al., 2010; 
Henry et al., 2009). These aged glia and their primed inflammatory profiles therefore 
place elderly at a higher risk of hyper-inflammatory reactions to acute CNS insults 
such as stroke or traumatic brain injury, possibly underlying the poorer outcomes 
accompanying advanced age.  
While no durable subsets have been identified in the healthy adult brain at 
steady state, a population of CD11C+ microglia consistently emerges in both aging and 
disease settings and can be detected in rodents and humans. Through 
immunohistochemistry combined with single cell and bulk transcriptomic 
approaches, these CD11C+ microglia have been reported to arise in response to the 




models (Kamphuis et al., 2016; Keren-Shaul et al., 2017; Krasemann et al., 2017; 
Mrdjen et al., 2018), as well as in other models of neurodegeneration and aging (Chiu 
et al., 2013; Holtman et al., 2015; Spiller et al., 2018; Wlodarczyk et al., 2014). In 
rodents, CD11C+ microglia, currently described as disease-associated microglia 
(DAM) or microglia subset expressing a neurodegenerative phenotype (MGnD), 
express high levels of CD85K, CLEC7A and Galectin-3 on their surface, while 
downregulating the surface markers TMEM119 and CX3CR1, which are typically 
associated with homeostatic microglia. MGnD were shown to directly arise in 
response to the phagocytosis of apoptotic neurons in vivo and are dependent on the 
APOE/TREM2 pathway for their phenotypic transformation (Krasemann et al., 2017). 
DAM/MgnD do not appear to upregulate the expression of common pro-
inflammatory cytokines, despite their association with disease pathology, raising the 
question as to whether these subsets propagate or dampen disease pathology. In 
support of the latter, TREM2 signaling can restrain inflammatory responses by 
negatively regulating Toll-like receptor 4 (TLR4)-mediated NFkB activation through 
antagonization of signaling downstream of protein kinase C (PKC) (Hamerman et al., 
2006; Yao et al., 2019). Single-nuclei RNA sequencing (snRNAseq) of cortices from 
Trem2–/– 5XFAD mice demonstrated that engagement of the DAM program requires 
TREM2 expression on microglia (Zhou et al., 2020). Restriction on the ability of 
microglia to proliferate and convert to DAM led to increased neuritic dystrophy in AD 
mouse models, suggestive of a protective inflammatory role for TREM2-dependent 




post-mortem human brain samples and the human AD brain snRNAseq signatures 
are distinct from those observed in the 5XFAD murine model, AD patients bearing the 
TREM2-R62H hypomorphic variant displayed a less reactive microglia phenotype, 
supporting the requirement for TREM2 in AD-induced microgliosis in humans (Zhou 
et al., 2020).  
In addition to the DAM/MGnD, dark microglia were recently described as a 
subset identifiable by their condensed, electron-dense cytoplasm visible by 
transmission electron microscopy (Bisht et al., 2016). In murine hippocampus, dark 
microglia were frequently observed in instances of disrupted normal homeostasis: 
chronic stress, aging, AD pathology (Bisht et al., 2016). In APP/PS1 mice, dark 
microglia expressed high levels of TREM2 and associated with plaques, where they 
also surrounded dystrophic neurons (Bisht et al., 2016). Unfortunately, there are no 
current methods to characterize these cells beyond TEM, limiting our understanding 
of this microglia subset or state.  
 While DAM, PAM, MGnD and dark microglia subsets clearly arise in response 
to developmental and neurodegenerative changes, there are currently no clearly 
defined subsets described in the healthy brain. Given the wide array of functions 
carried out by microglia, the diverse nature of the substrates cleared from the CNS, 
and the regional diversity hinted through transcriptomics, there are undoubtedly 
other microglia subsets yet to be discovered. Identifying and characterizing novel 
functional subsets in the unperturbed brain would potentially grant insight into 




CHAPTER TWO: RESULTS 
Adapted from Burns et al., eLife 2020.  
(Distributed under Creative Commons Attribution license) 
Cellular autofluorescence identifies two discrete microglia subsets 
Based on the observation that certain peripheral myeloid populations are 
highly autofluorescent, we initially included an empty fluorescence channel in our 
microglia flow cytometry analyses. Doing so revealed an unexpected bimodal 
distribution of autofluorescence (AF) intensity in CD45dimCD11B+ microglia isolated 
from 6-month old naïve C57BL/6 mice (Figure 4A and Figure 5A). This bimodal 
distribution identified two subsets of microglia: an AF-positive (AF+) subset showing 
a strong AF signal, and an AF-negative (AF–) subset which displayed no or minimal 
levels of AF. The two subsets appeared at a highly reproducible ratio of 1:2.5 (AF–
:AF+), with an average frequency of AF+ microglia of 71 ± 1.2% (n=13; CV=1.6%) 
(Figure 5B). To further characterize the spectral properties of the AF signal, we 
included additional empty fluorescence channels. The AF signal showed maximal 
intensity in the 660-735 nm emission range upon excitation with a 488 nm (Blue) 
laser but was also detected across multiple combinations of laser excitation 
wavelengths and emission filter ranges (Figure 4B). Extraction of single cell-level data 
from flow cytometry analyses revealed that the majority of microglia that were either 
positive or negative for AF in the Blue-710 nm AF channel were also positive or 




channels such as Red-780 nm for instance, 10 to 20 % of the cells that were positive 
in Blue-710 nm appeared low or negative, which likely resulted from a differential 
sensitivity of the channels used to detect AF as shown in Figure 4B by the differential 
brightness of the AF+ population in those two channels. Both AF microglia subsets 
were detected across different regions of the brain and while there were minor 
differences in the frequency of AF+ microglia between regions, AF+ cells displayed 
similar levels of AF signal in cerebellum, cortex and hippocampus (Figure 5C,D). Both 
AF+ and AF– subsets of microglia were positive for microglia homeostatic markers, 
including CX3CR1, P2RY12 and TMEM119 (Figure 4D and Figure 5E). Finally, there 
were no gender differences observed in the frequency of AF+ microglia nor the 
intensity of AF (Figure 5F,G). This observation was conserved across species as 
microglia isolated from the brains of 3- to 4-year old Cynomolgus monkeys showed a 
very consistent bimodal pattern of AF in the Blue-710 nm channel with 80 ± 3.6 % of 
microglia that were AF+ on average (Figure 4E,F). Altogether, these analyses 
identified cellular AF as a novel photophysical property for discriminating two 
discrete subsets of microglia present at steady-state and conserved between rodents 








Figure 4: Cellular autofluorescence identifies two discrete and novel microglia 
subsets. 
(A) Representative flow cytometry scatterplot showing CD45 and CD11B surface levels in a brain 
single cell suspension and histogram of autofluorescence (AF) signal in 
DAPI− CD45dim CD11B+ microglia detected with a blue laser and 710 nm detector. (B) Representative 
flow cytometry histograms of AF intensity in the entire microglia population for multiple excitation 
lasers and emission filters. (C) Heatmap of AF signal detected across multiple cytometer channels 
(columns) in 500 single microglial cells (rows) and hierarchically clustered by Manhattan distance. (D) 
Representative flow cytometry histograms of TMEM119, CX3CR1 and P2RY12 surface levels in 
AF+ and AF− microglia subsets. (E) Representative flow cytometry scatterplots used to identify 
microglia in brain single cell suspensions from Cynomolgus macaques and representative histogram 
of AF levels detected in microglia. (F) Quantitation of results presented in (E). (G) Representative 
scatterplots of AF levels detected in CD45dimCD11B+ microglia and corresponding microscopy images 
of selected AF+ and AF− cells (highlighted in orange and numbered in the scatterplots and images) 
analyzed using imaging flow cytometry. Scale bar = 7 μm. (A, B) Representative of n = 12 animals from 
at least four independent experiments. (D) n = 6 animals from at least two independent experiments. 
(E, F) n = 5 animals from two independent experiments. B = blue laser, R = red laser, YG = yellow 
green; AF = autofluorescence; BF = bright field; SSC = side scatter. 
 
The autofluorescence signal in AF+ microglia originates from intracellular organelles 
To define the subcellular origin of the AF signal in microglia, we utilized 
imaging cytometry. Microscopy images of AF+ cells identified by the fluorescence 
intensity detected in two empty channels (Figure 4G) revealed that the AF signal was 
not diffusely distributed throughout the cellular volume but was punctate and 
localized within intracellular organelles. The subcellular AF compartments were 
observed in all tested AF channels and systematically colocalized (Figure 5H, I). AF– 
cells did not display detectable AF subcellular compartments in any of the tested 
channels, altogether establishing that these two subsets of microglia, identified solely 
by their AF profiles, differed by the presence of highly autofluorescent intracellular 










Figure 5: Autofluorescence identifies two discrete microglia subsets across brain 
regions and in both male and female mice. 
(A) Flow cytometry gating strategy used to identify microglia and AF subsets. (B) Percent 
AF+ microglia detected in 6-month-old mice across multiple independent experiments. Significance 
established with 1-way ANOVA. n = 3 per experiment. (C) Percent AF+ microglia and (D) relative AF 
intensity detected in 6-month-old mice from indicated brain regions. n = 6 animals from two 
independent experiments. Data are presented as the mean ± SD and significance established with (C) 
Welch ANOVA with Dunnett’s T3 multiple comparisons test post-hoc and (D) 1-way ANOVA. (E) 
Relative levels of TMEM119, CX3CR1 and P2RY12 in AF+ and AF− microglia subsets calculated as net 
geometric mean fluorescence intensity after subtraction of background AF signal and normalization to 
AF− subset. Data are presented as the mean ± SD and significance established with paired t-tests. (F) 
Relative AF intensity and (G) proportion of AF+ microglia in age-matched male and female mice. 
Significance established with unpaired Student’s t-test. n ≥ 5 animals per gender from two 
independent experiments. (H) Representative images of AF signal detected in two flow cytometer 
channels and overlay of corresponding signals illustrating colocalization of AF signal. (I) Quantification 
of the colocalization of signal between two AF channels shown in (H), calculated as the log-transformed 
Pearson’s correlation coefficient. A value of 0 indicates no linear correlation and value of 10 indicates 
maximal correlation. All data presented as mean ± SD. AF = autofluorescence; FSC = Forward scatter; 
B = blue laser; YG = yellow green laser. Expt. = experiment; ns = not significant, *p<0.05. ***p<0.001. 
 
AF signal intensity increases linearly with aging, but solely within AF+ microglia 
In contrast to the punctate AF signal detected in 3-month old animals, imaging 
flow cytometry applied to naïve mice from a range of ages revealed that AF 
subcellular structures became largely confluent in 10-month old animals and 
occupied a larger fraction of the cytosol (from 11 µm2 to 17 µm2 on average in 3- and 
10-month old animals, respectively) (Figure 6A,B). Consistent with these results, flow 
cytometry analyses established a nearly linear increase of AF signal intensity in AF+ 
microglia with aging (Figure 6C,D), resulting in a cumulative 3-fold increase of AF 
signal between 3- and 12-month old mice across multiple fluorescence channels 
(Figure 6D and Figure 7A). While a clear AF+ population was not detectable in mice 
aged 15 days post-natal or younger, a bimodal distribution appeared as early as 30 




In contrast, age-dependent increases in cellular AF were not detected in peripheral 
CD11B+ cells residing in the spleen (Figure 7D). Despite the large increase in the AF 
signal observed in AF+ cells, their frequency remained largely unchanged during 
aging, decreasing only slightly from 75% to 72% from 3 to 12 months of age (Figure 
6E). Finally, neither the proportion of AF– cells (Figure 6E) nor the area of 
intracellular AF signal detected in AF– microglia (Figure 6A,B) were altered by aging, 









(A) Representative imaging flow cytometry images and (B) corresponding quantitation of average AF 
area per cell in AF+ and AF− CD45dimCD11B+ microglia isolated from 3- and 10-month old mice. 
Significance established with 2-way ANOVA followed by Sidak’s post-hoc correction, n = 4000–8000 
cells. (C) Representative flow cytometry histogram and (D) corresponding quantitation of AF intensity 
in AF+ CD45dim CD11B+ microglia isolated from mice at the indicated ages and presented as normalized 
values to AF levels observed in 3-month-old animals. Significance established with 1-way ANOVA 
followed by Dunnett’s post-hoc. The line depicts the linear regression (R2 = 0.95). (E) Percent 
AF+ microglia at indicated ages. Significance established with 1-way ANOVA followed by Dunnett’s 
post-hoc. All data are presented as mean ± SD. For panels C-E, n ≥ 6 animals per age from at least two 






Figure 7: Microglial autofluorescence increases with age in multiple flow cytometry 
channels and is unique to microglia. 
(A) Representative flow cytometry histograms of AF intensity in the entire microglia population for 
multiple cytometer excitation lasers and emission filter wavelengths overlaying AF signal detected at 
indicated ages. Representative of n ≥ 6 animals per age group representative of at least two 
independent experiments. (B) Representative flow cytometry histograms and (C) quantitation of AF 
intensity detected at the indicated days post-birth. Shaded-grey histogram in overlays is 
representative of P7 microglia. n ≥ 3 mice per age, one independent experiment. (D) Representative 
flow cytometry histogram overlays of AF in splenocytes and microglia at the specified ages. n = 3 mice 





AF+ microglia selectively accumulate intracellular storage bodies with age 
We next isolated AF+ and AF– microglia from 3-month and 18-month old mice using 
fluorescence-activated cell sorting (FACS) and performed transmission electron 
microscopy (TEM) analyses. At 3 months of age, the intracellular organization of AF 
microglia subsets differed in that AF+ cells almost systematically contained large 
storage bodies filled with osmophilic electron-dense deposits (Figure 8A). These 
electron-dense storage bodies were observed in 80% of AF+ microglia whereas only 
46% of AF– microglia contained electron-dense organelles (Figure 8A,C). When 
observed in AF– cells, storage bodies were devoid of complex storage material and 
were more regularly shaped than those observed in AF+ cells (Figure 8A). In aged 
mice, the storage bodies within AF+ microglia changed dramatically in both size and 
complexity (Figure 8A). Between 3 and 18 months of age, the percentage of visible 
cytoplasm occupied by storage bodies increased from 9% to 23% on average and 
approximately 30% of AF+ cells from aged mice contained AF material that occupied 
more than a third of the cytoplasm (Figure 8D). The ultrastructural composition of 
the storage bodies in AF+ cells varied with frequent curvilinear (black arrowheads) 
and fingerprint-like profiles (red arrowheads) (Figure 8B). White, linear, rod-like 
material with fine-tipped ends (white arrowheads) were observed within membrane-
bound lipoid bodies and closely resembled cholesterol crystal deposits (Figure 8B). 
Most prominent, however, was the proportion and volume of lipid droplets 




bodies and the proportion of the cytosol occupied by storage bodies remained 
unchanged in the AF– microglia subset (Figure 8A,C,D).  
In addition to these ultrastructural differences, AF+ cells expressed higher 
levels of LAMP1 and CD68 compared to AF– cells (Figure 8E,F), indicating an 
enlargement of endolysosomal storage compartments in AF+ cells. Furthermore, a 
gradual age-dependent increase in LAMP1 and CD68 protein levels was observed in 
the AF+ subset (Figure 8E,F) whereas AF– microglia did not show changes. Altogether 
these observations indicated that AF+ microglia differed from AF– cells by their 









Figure 8: AF+ microglia selectively accumulate intracellular storage bodies with age. 
(A) Representative TEM images of sorted microglia subsets from 3- to 18-month-old mice. Red 
arrowheads point to storage bodies. Scale bars = 2 µm. Insets depict higher magnification images of 
selected AF+ microglia (dashed square lines). Inset scale bars = 500 nm. (B) Representative TEM 
images of storage bodies observed within aged AF+ microglia. Black arrowheads, curvilinear storage 
material; white arrowheads, crystal bodies; red arrows, fingerprint-like storage material; asterisks, 
lipid storage content. Scale bars = 500 nm. (C) Frequency of cells containing storage bodies in microglia 
AF subsets sorted and pooled from n = 10 mice at the indicated ages. Significance established with 
Fischer’s exact test. n = 48–59 cells/group. (D) Average percent of cytosolic area occupied by storage 
material in cells containing at least one storage body. Significance established with 2-way ANOVA 
followed by Tukey’s post-hoc. n = 11–21 cells/group. (E) Representative flow cytometry histograms 
and (F) corresponding quantitation of LAMP1 and CD68 staining in AF− and AF+ subsets at indicated 
ages. Relative levels of LAMP1 and CD68 calculated as net geometric mean fluorescence intensity after 
subtraction of background AF signal and normalization to AF intensity detected in the AF− subset at 3 
months of age. Significance established with 2-way repeated-measures ANOVA followed by Tukey’s 
post-hoc. n ≥ 6 animals per age from at least two independent experiments. All data presented as 
mean ± SD. ns = not significant, **p<0.01 ***p<0.001. 
 
Microglia AF subsets exhibit differential population dynamics upon depletion and 
replenishment of the microglia niche 
To explore the cellular dynamics and ontogenic relationships between these 
two novel subsets of microglia, we depleted microglia in 14-month old mice with the 
CSF1R-small molecule antagonist BLZ945 (Krauser et al., 2014; Pyonteck et al., 2013). 
Twenty-four hours following the treatment period, depletion was nearly complete, as 
assessed by the remaining frequency and absolute numbers of microglia (Figure 9A,B 
and data not shown). Consistent with previous reports (Huang et al., 2018; O’Neil et 
al., 2018), microglia rapidly repopulated the CNS at 7 and 14 days post-treatment, 
recovering on average to 25% (at 7 days) and 87% (at 14 days) of steady-state 
microglia numbers (Figure 9A and data not shown). However, repopulation by AF+ 
and AF– subsets showed distinct kinetics. While AF– microglia cell numbers reached 




levels by that time (Figure 9B). At 14 days repopulating AF+ cell numbers only 
reached 14% of steady-state AF+ values in vehicle-treated mice while the 
repopulating AF– subset surpassed steady-state levels by approximately 2-fold 
(Figure 9B) before normalizing to steady-state levels at day 70. Altogether these 
results established that the AF– subset was the first subset to repopulate the depleted 
brain while the repopulation by AF+ cells was delayed, suggesting a possible 
conversion from AF– to AF+ state during repopulation.  
Supporting this hypothesis, the AF intensity of the repopulated microglia 
slowly increased from barely detectable levels at day 7 to slightly increased levels at 
day 14, ultimately returning to a bimodal distribution by day 70 (Figure 9C,D). Even 
at the latter timepoint, only a small fraction of this newly-formed AF+ subset (19% on 
average) displayed AF intensity levels comparable to those seen in vehicle-treated 
mice (Figure 9C,D and Figure 10A,B) while most repopulating AF+ cells displayed 
35% weaker AF signal intensity on average. This gradual accumulation of AF material 
over time in repopulating microglia supported the possibility that AF+ microglia were 
derived from the conversion of AF– cells during replenishment. Further validating this 
conclusion, 56% of microglia displayed positivity for the proliferation-associated 
marker KI-67 at day 7 before returning to steady-state values by day 14 (Figure 9E,F). 
Because AF+ microglia were virtually absent during this early repopulation phase 
(Figure 9B), these proliferation kinetics implied that the AF– subset of microglia was 




compartment following depletion and that AF+ microglia were derived from the 








Figure 9: Microglia AF subsets exhibit differential population dynamics upon 
depletion and replenishment of the microglia niche. 
(A) Representative flow cytometry scatterplots showing CD45 and CD11B surface levels in brain 
single cell suspensions from mice at indicated timepoints post treatment with vehicle or BLZ945 and 
(B) corresponding quantitation of absolute cell numbers of AF+ and AF− microglia post-treatment. 
Significance established with 1-way ANOVA followed by Dunnett’s post-hoc test. (C) Representative 
flow cytometry histograms and (D) corresponding quantitation of AF intensity in the entire microglia 
population detected across multiple combinations of excitation lasers and emission filters and 
normalized to levels observed in vehicle-treated mice. In the scatter plot, the line represents the 
linear regression (R2 = 0.99). Significance established with 1-way ANOVA followed by Dunnett’s post-
hoc test for each AF channel. (E) Representative flow cytometry scatterplots depicting KI-67 levels 
and AF intensity in microglia isolated at indicated time points post-treatment and (F) corresponding 
quantitation of the percent microglia positive for KI-67. Significance established with Welch’s ANOVA 
followed by Dunnett’s T3 post-hoc. n ≥ 8 animals per genotype group from at least two independent 
experiments. All data represented as mean ± SD. d = day; h = hour; B = blue laser; YG = yellow green 




Figure 10: Repopulating microglia exhibit lower levels of AF. 
(A) Representative flow cytometry histogram and (B) corresponding quantitation of microglia subset 
proportions 70 days after treatment with vehicle or BLZ945. Significance established with 2-way 
repeated measures ANOVA followed by Sidak’s post-hoc. n = 4 animals per group representative of 







Proteomic analysis of isolated AF+ and AF– microglia subsets reveals molecular 
differences in endolysosomal, autophagic and metabolic pathways. 
To determine whether microglia AF subsets were distinct at the molecular 
level, FACS-isolated AF+ and AF– microglia were analyzed by nano liquid 
chromatography mass spectrometry (nLC-MS). A total of 4,231 proteins were 
detected by label-free LC-MS/MS and after filtering for proteins quantified in at least 
50% of samples in either subset, 3,492 remained for analysis. 351 proteins showed 
significant differences in abundance between AF+ and AF– microglia (Benjamini-
Hochberg adj. p value < 0.01, fold-change > |1.3|), with 254 and 97 upregulated and 
downregulated differentially expressed proteins (DEPs), respectively (Figure 11A). 
When ranked by significance, 32 of the top 50 DEPs upregulated in AF+ microglia were 
associated with endolysosomal biology, among which was LAMP1, validating prior 
flow cytometry results (Figure 11E,F). Furthermore, a large number of lysosomal 
enzymes were upregulated in AF+ microglia including cathepsins (CTSA, CTSB, CTSD, 
CTSF, CTSL, CTSZ) as well as several enzymes involved in lysosomal degradation such 
as amidases (ASAH1, GBA, NAAA), thioesterases (PPT1, PSAP, NAGA), proteases 
(TPP1, LGMN) and glycosyl hydrolases (HEXA, HEXB, GLB1). Many other DEPs 
involved in the biology, trafficking, or fusion of endosomes with lysosomes and 
phagosomes (ATP6V0D1, SCARB2, GRN, ARL8B, TOM1, STX7, TMEM55B) were also 
upregulated in AF+ microglia. Underscoring the importance of these proteins towards 
maintaining proper CNS homeostasis, genetic perturbations in 15 of the top 50 DEPs 




Niemann-Pick. Lastly, DEPs that are typically associated with neurons (CBLN1, 
CBLN4, SNAP25), oligodendrocytes (MOBP, SYNE2) and astrocytes (GJA1) were 
detected at significantly higher levels in AF+ microglia, suggesting functional 
differences in either the phagocytic capacity of this subset or its ability to fully 
degrade ingested material. 
To systematically explore additional pathways distinguishing AF subsets at 
the molecular level, Gene Ontology (GO) term enrichment was performed with 
Panther (Figure 11B and Appendix II). DEPs upregulated in AF+ microglia were 
enriched in pathways related to intracellular vesicle-mediated transport, lysosomal 
organization, protein transport, lipid catabolic processes and regulation of TOR 
signaling (Figure 11B,C). DEPs downregulated in AF+ microglia showed enrichment 
in RNA-related biological processes (transcription, RNA metabolism, splicing) and 
chromatin silencing. In agreement with GO term enrichment analysis, the top 
canonical pathways identified by Ingenuity Pathway Analysis (IPA) as enriched in AF+ 
microglia included phagosome maturation, autophagy, numerous catabolic pathways 
(amino acid and glutaryl-coA catabolism, ketogenesis and fatty acid β-oxidation), 
mitochondrial dysfunction, and pathways that were indicative of mTOR deregulation 
(mTOR, AMPK) (Figure 11D). Finally, upstream regulators predicted to explain the 
distinct proteome displayed by AF+ cells included transcription factors involved in 
the regulation of cell cycle, senescence and apoptosis (TP53, MYC, CDKN2A), ER 
stress and unfolded protein response (XBP1), autophagy and lysosomal biogenesis 




these results established that AF+ microglia expressed a unique proteome 
characterized by an increased representation of endolysosomal, autophagic, 










Figure 11: Proteomic analysis of isolated AF+ and AF− microglia subsets reveals 
molecular differences in endolysosomal, autophagic and metabolic pathways. 
(A) Volcano plot comparing protein abundance in AF+ and AF− microglia (x-axis: Log2 abundance 
difference, y-axis: negative log Benjamini-Hochberg adjusted p value from two-tailed Student’s t-test) 
with most-differentially expressed proteins annotated. Red lines: significance cutoffs (adjusted p 
value < 0.01, |Fold change| > 1.3). (B) Scatter plot displaying adjusted p value and GO term fold-
enrichment results among differentially expressed proteins (DEPs) upregulated in AF+, with selected 
pathways highlighted. Dot color indicates number of proteins within GO pathway detected in the 
dataset (see legend). (C) Volcano plots comparing protein levels in AF+ and AF− microglia with 
indicated GO term signatures overlaid in red. p value, χ2 statistical test for bias in distribution of GO 
term pathway members. (D) Top canonical pathways and (E) upstream regulators identified by IPA as 
differentially regulated between AF subsets. (D) Bars and dots respectively indicate p values and the 
percent of pathway proteins detected. (D, E) Predicted activation or inhibition of pathway or 
transcriptional regulator is indicated by positive and negative Z-scores, respectively, see legend. 
Analysis based on 351 DEPs identified using adjusted p value < 0.01 and fold change > |1.3|. 
 
Myelin, Fc receptor-mediated and TREM2-mediated phagocytosis are not dominant 
mechanisms contributing to microglia AF accumulation 
Given the abundance of intracellular storage bodies and the increased 
detection of proteins involved in endocytosis and phagosome maturation observed in 
AF+ microglia, we investigated whether differential phagocytosis of myelin debris 
contributed to the subset-specific accumulation of AF storage material. Shiverer mice 
(Mbpshi/shi) harbor a spontaneous autosomal-recessive mutation in myelin basic 
protein (MBP) which results in defective myelin compaction and physical instability 
of the myelin sheath (Privat et al., 1979; Weil et al., 2016). Despite this myelin 
deficiency, there were only small differences in the frequency of AF+ cells, AF signal 
intensity, and LAMP1 levels in microglia from 70-day old Mbpshi/shi mice as compared 
to control animals (Figure 11A,B). Importantly, however, microglia from Mbpshi/shi 
mice upregulated markers known to be induced by the phagocytosis of apoptotic 




Altogether, these observations validated that myelin instability was associated with 
increased microglia phagocytic activities in this model while also indicating that 
phagocytosis of unstable myelin sheaths or cellular debris was unlikely to be the 
primary driver of AF accumulation with aging.  
To explore whether other phagocytic activities were contributors to AF 
accumulation, we examined Fc-receptor mediated and Triggering Receptor 
Expressed on Myeloid cells 2 (TREM2)-mediated phagocytosis using Fcer1g–/– mice, 
which lack the common Fc-gamma chain required for functional expression of 
activating Fc-receptors (Takai et al., 1994), and Trem2–/– mice, which were reported 
to have microglia defective in the engulfment of apoptotic neurons, myelin debris, and 
synapses (Hsieh et al., 2009; Cantoni et al., 2015; Wang et al., 2015). Microglia isolated 
from 9-month old Fcer1g–/– and 6-month old Trem2–/– mice displayed no differences 
in the frequency of AF+ microglia or AF intensity (Figure 12C,E), nor did they differ in 
LAMP1 levels when compared to controls (Figure 12D,F). Together, these results 
indicated that the generation of microglia AF was not dependent on either Fc-











Figure 12: The accumulation of AF storage bodies in microglia is genetically 
controlled. 
(A, C, E, G, H, J) Representative flow cytometry histograms and quantitation of AF subset frequency 
and/or AF signal intensity in AF+ microglia isolated from mice of indicated genotypes. Significance 
established with unpaired Student’s t-test (A, C, E, G), 2-way repeated measures ANOVA followed by 
Sidak’s post-hoc (H), and 1-way ANOVA followed by Tukey’s post-hoc (J). (B, D, F, I, K) Quantitation of 
LAMP1 levels in microglia isolated from mice of indicated genotypes, calculated as net geometric mean 
fluorescence intensity after subtraction of background AF signal and normalization to AF intensity 
detected in AF− microglia from wild-type age-matched control mice. Significance established with 
unpaired Student’s t-test (B, D, F, I) and 1-way ANOVA followed by Tukey’s post-hoc (K). n ≥ 6 animals 
per genotype group from at least two independent experiments. All groups were age-matched and all 
data presented as mean ± SD. AF = autofluorescence; B = blue laser; YG = yellow green laser; ns = not 




Figure 13: Characterization of microglia isolated from Mbp-deficient mice. 
(A) Representative flow cytometry scatterplots depicting CLEC7A levels and AF intensity in microglia 
from mice of indicated genotypes and (B) corresponding quantitation of percent microglia positive for 
CLEC7A. Significance established with Welch’s t-test. **p<0.01. 
 
Disruption of autophagy and lysosomal processing alter AF accumulation within AF+ 
microglia 
Given that the proteomic analysis identified upregulation of autophagic 
proteins in AF+ microglia, we reasoned that the recycling of cellular components and 
their subsequent lysosomal degradation might contribute to the accumulation of AF 
material in microglia. To disrupt the formation of autophagic vacuoles in microglia, 
Atg5flox/flox mice were crossed to the Cx3cr1CRE-ERT2 mouse line and treated with 




(Figure 14A), hereafter referred to as Atg5–/–. In 12-month old Atg5–/– mice, there was 
a significant decrease both in the frequency and the relative AF intensity of the AF+ 
subset (Figure 12G). Interestingly, in Atg5–/– mice the distribution of AF intensity in 
AF+ cells broadened significantly compared to controls. To better characterize this 
change in distribution, we divided the AF+ subset into AFdim and AFhi populations 
(Figure 12G). In Atg5–/– mice, the proportion of AFhi microglia was decreased 
compared to Atg5+/+ (30% versus 36%, p = 0.012, Figure 12H). While no difference 
was observed in LAMP1 (Figure 12I), CD68 was significantly lower in AF+ microglia 
from Atg5–/– mice (Figure 14B).  
We next examined the contribution of lysosomal pathways in the regulation of 
AF accumulation. To this end, we isolated microglia from Cln3∆ex7/8 homozygous 
knock-in mice (hereafter referred as Cln3KI/KI), which express the most common loss-
of-function allelic variant of the lysosomal gene Cln3 found in patients with juvenile-
forms of NCL (Cotman et al., 2002). While the proportion of AF+ microglia was 
modestly decreased in 5-month old Cln3KI/KI mice, AF+ microglia isolated from 
Cln3KI/KI animals showed a striking increase in AF signal intensity compared to 
microglia from control mice (Figure 12J). Furthermore, the AF signal intensity was 
not equivalently increased across the entire light emission spectrum, with the highest 
difference (2.4-fold on average) observed in the short emission wavelengths (525 
nm) whereas differences were more limited at 585 nm and no longer detected at 710 
nm (Figure 12J), likely reflecting differences in both the magnitude and composition 




signal in wild-type mice (Figure 8E,F), LAMP1 protein was increased by more than 2-
fold in AF+ microglia from Cln3KI/KI mice (Figure 12K). In contrast, LAMP1 levels in 
AF– microglia remained unchanged across all genotypes (Figure 12K), establishing 
that lysosomal dysfunction selectively affected the subset of microglia accumulating 
AF material. In summary, autophagy and lysosomal dysfunction respectively 
attenuated and increased the accumulation of AF material in AF+ microglia, thereby 
establishing autophagy and lysosomal biology as important mechanisms contributing 
to the formation of the AF+ microglia subset.  
 
 
Figure 14: Characterization of microglia isolated from Atg5-deficient mice. 
(A) Relative transcript expression of Atg5 quantified by RT-qPCR of FACS-isolated microglia from mice 
of indicated genotypes 1 or 8.5 months after tamoxifen-induced recombination. Significance 
established with unpaired Student’s t-test. (B) Quantitation of CD68 levels in microglia isolated 
from Atg5−/−mice, calculated as net geometric mean fluorescence intensity after subtraction of 
background AF signal and normalization to AF intensity detected in AF- microglia from wild-type age-
matched control mice. Significance established with unpaired Student’s t-test. n ≥ 6 animals per 
genotype group from at least two independent experiments. AF = autofluorescence; ns = not 





Advanced aging and lysosomal dysfunction lead to the preferential cellular loss of the 
AFhi microglia population 
Given that the relative proportion of AF+ microglia remained steady during the first 
year of life (Figure 6E), we next analyzed AF microglia subsets during advanced aging, 
defined in mice as 18 to 24 months of age. Similar to what we observed between 3 
and 12 months of age (Figure 6C), the maximal intensity of AF in AF+ cells continued 
to increase between 12 and 24 months of age (Figure 15A). In contrast to the largely 
bimodal distribution of AF seen during the first 12 months of age, the distribution 
observed at 24 months of age was more continuous, with a noticeable downward shift 
in AF intensity detected on a per cell basis (Figure 15A). To quantify this change in 
distribution, we divided the AF+ subset into AFdim and AFhi populations as done 
previously (Figure 12G). While at 12 months of age 50% of microglia were AFhi, this 
population decreased to 32% on average by 24 months of age, with a concomitant 
increase in AFdim and AF– cells (Figure 15B). This apparent relative loss of the AFhi 
microglia subset was accompanied by a 31% decrease in the overall number of 
microglia recovered from 24-month old mice as compared to 12-month old animals. 
This decreased recovery did not affect all AF microglia subsets equally but was 
uniquely attributed to a 58% decrease in the absolute number of AFhi cells (Figure 
15C). 
To explore the possible factors involved in the preferential loss of AFhi 
microglia with age, we examined rates of proliferation and cell death in adult and aged 




± 0.9 %, n=8) as compared to adult mice (1.9 ± 0.2 %, n=7) and was mostly attributed 
to AFhi and AFdim cells, which showed a 2-fold increase in the cell death rate at 24 
months of age as compared to 12 months of age (Figure 15D,E). By contrast, the cell 
death rate seen in AF– cells did not significantly increase between 12 and 24 months 
of age. When quantifying specifically early-apoptotic (AnnexinV+ DAPI–) cells, AFhi 
and AFdim microglia exhibited similar relative increases in early-apoptotic rates 
between 12 and 24 months of age (Figure 16A), altogether suggesting that increased 
rates in apoptotic and necrotic death were both contributing to the overall 2-fold 
higher cell death rate seen in AFhi and AFdim microglia with aging. Unlike cell death 
rates, homeostatic proliferation rates at 12 months of age were generally higher in 
AF– microglia than in AFdim (by 2-fold on average) and AFhi cells (by 7-fold on average) 
and did not change with aging, with the exception of AFhi microglia which showed a 
2.6-fold increase in proliferative rate between 12- and 24-months of age (Figure 
15F,G).  
Because microglia from Cln3KI/KI mice accumulated higher levels of AF in the 
AF+ population (Figure 12J), we reasoned that accelerated accumulation of AF 
material may exacerbate the differences in AF subset survival. Accordingly, as early 
as at 9 months of age and more prominently at 18 months of age, we observed a 
marked decrease in the frequency of the AFhi subset, using channels that either 
showed increased AF signal at 5 months of age (e.g., Blue-525 nm) or channels that 
showed no increase in AF signal at this age (e.g., Blue-710 nm) (Figure 15H and Figure 




reductions in microglia cell numbers (by 30% and 85%, respectively, for AFdim and 
AFhi microglia, Figure 15I) and increases in overall cell death and early-apoptotic 
rates in AFhi and AFdim microglia, but not AF– cells from Cln3KI/KI mice as compared to 
control mice (by 3.0- and 2.0-fold, respectively, Figure 15J and Figure 16D). 
Altogether, these observations supported a model where the age-associated 
progressive accumulation of AF material directly caused increased cell death rates, 
thereby leading to the selective decline of the AF+ subset observed during natural 
aging and the premature collapse of this subset upon accelerated accumulation of AF 








Figure 15: Advanced aging and lysosomal dysfunction lead to the preferential cellular 
loss of the AFhi microglia population. 
(A) Representative flow cytometry histograms and (B, C) corresponding quantitation of AF subset 
frequencies (B) and absolute cell numbers (C) in 12- and 24-month-old naïve mice. Significance 
established with 2-way repeated measures ANOVA followed by Sidak’s post-hoc. (D–G) Representative 
scatterplots depicting DAPI and AnnexinV staining (D) and KI67 and CX3CR1 staining (F) in microglia 
subsets from 12- and 24-month-old mice and corresponding quantitation of the frequency of 
AnnexinV+ (E) and KI67+ (G) cells in each microglia subset. Significance established with 2-way 
repeated measures ANOVA followed by Sidak’s post-hoc. (H) Representative flow cytometry 
histograms of AF intensity in microglia from mice of indicated genotypes and ages and detected using 
two distinct cytometer channels and (I) corresponding quantitation of absolute cell numbers of 
microglia subsets in 18-month-old animals. Significance established with 2-way ANOVA followed by 
Sidak’s post-hoc. (J) Quantitation of percent microglia positive for AnnexinV in indicated AF subsets 
from 18-month-old animals of indicated genotypes. (K–L) Quantitation of CellROX DeepRed ROS-
indicator staining in microglia subsets from mice at indicated ages and after subtraction of background 
AF signal at (K) baseline and (L) after treatment with ROS inducer tBHP. (M) Quantitation of 
Mitotracker dye staining as an indicator of mitochondrial content in microglia subsets from mice at 
indicated ages. Significance established with 2-way ANOVA followed by Sidak’s post-hoc. n ≥ 7 animals 
per genotype group from at least two independent experiments. All data presented as mean ± SD. 
AF = autofluorescence; B = blue laser; ROS = reactive oxygen species; tBHP = tert Butyl hydroperoxide; 








Figure 16: Lysosomal dysfunction leads to the preferential cellular loss of the 
AFhi microglia population. 
(A) Quantitation of the frequency of AnnexinV+, DAPI− microglia at 12- and 24 months of age in 
C57BL/6 mice. Significance established with 2-way repeated measures ANOVA followed by Sidak’s 
post-hoc (B) Quantitation of the frequency of microglia subsets in Cln3KI/KI mice at indicated ages. 
Significance established with 2-way repeated measures ANOVA followed by Tukey’s post-hoc. (C, D) 
Quantitation of the frequency of AF microglia subsets and (D) AnnexinV+ DAPI− microglia 
in Cln3KI/+ and Cln3KI/KI mice at 18 months of age. Significance established with 2-way repeated 
measures ANOVA followed by Sidak’s post-hoc. n ≥ 7 animals per group from at least two 
independent experiments. AF = autofluorescence. Data presented as mean ± SD. ns = not significant, 
*p<0.05, **p<0.01, ***p<0.001. 
 
The AF+ subset is associated with an increased production of reactive oxygen species 
Based on proteomic analyses, we hypothesized that the higher apoptotic rates 
observed in AF+ cells could result from mitochondrial dysfunction, the highly 
catabolic metabolism of AF+ cells or their reliance on fatty acid β-oxidation as a source 
of energy, all metabolic processes which are known to generate high levels of ROS. As 
measured by a ROS-sensitive cellular dye, AF+ microglia from 3-month and 24-month 
old mice displayed baseline ROS levels that were on average 2-fold and 2.4-fold higher 
than those observed in AF– microglia, respectively (Figure 15K). After treatment with 




generated ROS levels that were 1.5-fold and 2-fold higher than those observed in AF– 
microglia at 3 and 24 months of age, respectively (Figure 15L). tBHP-induced ROS 
generation increased with aging and this increase was selectively observed in AF+ 
microglia that generated 1.6-fold more ROS at 24 months than at 3 months of age 
(Figure 15L).  
To determine whether differences in mitochondrial content were contributing 
to the increased levels of ROS observed in AF+ cells, we assayed microglia cellular 
content using the Mitotracker probe. AF+ microglia exhibited, 1.5-fold and 1.6-fold 
higher levels of Mitotracker fluorescence on average than AF– cells at 3 and 24 months 
of age, respectively (Figure 15M). There was no age-dependent increase in 
Mitotracker signal detected for AF+ microglia. Together, these data established that 
AF accumulation in AF+ microglia was associated with increased levels of ROS, both 
at baseline and in response to tBHP treatment, which may contribute to the changes 





CHAPTER THREE: DISCUSSION 
Adapted from Burns et al., eLife 2020 
(Distributed under Creative Commons Attribution license) 
Generally, a cellular subset should exhibit shared properties with other cells 
within the cell type while exhibiting unique features and selective physiological 
functions that are independent of their microenvironment or external stimuli. It has 
therefore been suggested that true microglial subsets should be defined in 
unchallenged conditions by their intrinsic properties which translate into unique 
physiological functions during development or aging (Stratoulias et al., 2019). This 
report describes novel microglia subsets that precisely satisfy each criteria of this 
definition (Figure 17): (1) Cellular autofluorescence constitutes a cell-intrinsic 
photophysical parameter that unexpectedly distributed in a bimodal fashion in 
microglia; (2) The distinct subsets of microglia identified by this parameter were 
found in healthy, non-challenged conditions in both mice and non-human primates, 
irrespective of brain region or local microenvironment (e.g., various levels of myelin 
content such as in Shiverer mice) and independently of any specific stimulus or age 
(e.g., these subsets were present in young healthy brain as well as in aged animals); 
(3) AF+ cells selectively accumulated lysosomal storage bodies, therefore identifying 
the subset of microglial cells endowed with clearance functions in the brain and 
suggesting that this intrinsic AF property reflected unique physiological functions; 
(4) These subsets were detected longitudinally at a fixed ratio throughout most of 




abundance ratio between them. Microglia that were negative for autofluorescence 
were detected even in advanced aging conditions, excluding the possibility that these 
subsets could be simple cellular phenotypes. While DAM, MgnD, LDAM and PAM 
microglia states (Hagemeyer et al., 2017; Kamphuis et al., 2016; Keren-Shaul et al., 
2017; Krasemann et al., 2017; Marschallinger et al., 2020; Li et al., 2019) were 
previously described in disease settings, aging and during development, functionally-
defined populations of microglia have not been identified or characterized in steady-
state settings ‒ to the best of our knowledge ‒, despite the heterogeneity of microglia 
observed by mass cytometry and single cell transcriptomic methods (Hammond et 
al., 2019; Li et al., 2019; Masuda et al., 2019; Matcovitch-Natan et al., 2016; Mrdjen et 
al., 2018). The novel subsets described here, which we propose to name AF+ and AF–, 
are predicted to have distinct functions and potentially represent the first defined 
subsets of microglia in the unchallenged healthy brain.  
Lines of evidence point to a model where AF+ microglia derive from the 
gradual and synchronous conversion of a subset of AF– cells: (1) AF was found to 
linearly increase from 3 months to 12 months of age, indicative of a progressive and 
cumulative biological process during aging; (2) Microglia proliferation following 
depletion was largely restricted to the AF– subset which fully replenished within 14 
days; (3) The post-depletion re-emergence of the AF+ subset was delayed until after 
proliferation had subsided. One limitation of these repopulation experiments is that 
we were unable to exclude the possibility that a small number of surviving AF+ cells 




future lineage tracing experiments or the adoptive-transfer of congenically-labeled 
AF+ and AF- microglia into neonatal hosts as recently described (Hasselmann et al., 
2019) will allow to definitely establish the ontogeny relationship between these 
microglia subsets. Our repopulation results are in agreement with the reported 
decrease in both lipofuscin content and CD68+ lysosomal volume described by O’Neil 
and colleagues at 21 days following PLX5622-induced microglia depletion and 
repopulation (O’Neil et al., 2018). While the authors concluded that enforced 
microglia turnover reversed age-related lipofuscin accumulation, our data indicate 
that a discrete AF+ microglia population re-emerges post depletion and that 
repopulating AF+ microglia progressively accumulate AF with time, further 
establishing that AF accumulation is a progressive physiological process directly 
linked to aging. However, several important questions remain to be addressed in 
future studies, among which are: (1) the formal demonstration of the irreversibility 
of AF accumulation with aging; (2) the identification of the molecular cues 
responsible for the conversion from AF– to AF+ ; and (3) the elucidation of the 
mechanisms maintaining AF subset ratios.  
Historically, the gradual increase of AF in the brain with aging has been 
attributed to the accumulation of lipofuscin within postmitotic neurons and glial cells 
(Seehafer & Pearce, 2006; Xu et al., 2008; Nakanishi & Wu, 2009). Lipofuscin is 
characterized by a distinctive cytoplasmic accumulation of non-degradable 
fluorescent storage material comprised of highly crosslinked, polymeric and oxidized 




typically displays spectral excitation and emission maxima in the range of 320-480 
nm and 460-630 nm, respectively (Jung, Höhn & Grune, 2010; Moreno-García et al., 
2018; Warburton et al., 2007), the exact composition is known to vary between brain 
regions and cell types, likely impacting its precise spectral properties (Gilissen & 
Staneva-Dobrovski, 2013). In contrast, several exciting laser wavelengths (405, 488, 
561, 640 nm) led to the emission of AF in microglia while the AF emission spectrum 
was also characterized by an equally wide range of wavelengths (450–780 nm) 
observed on a per cell basis. The latter property suggests that the AF signal detected 
within each AF+ microglia originates from complex subcellular content that may only 
partially overlap with traditional lipofuscin detected in other cell types. For example, 
while ceroid and lipofuscin exhibit some overlapping characteristics, these storage 
materials have unique compositions that in turn display subtle spectral differences 
(Seehafer & Pearce, 2006). The possibility that microglia AF observed by flow 
cytometry is detecting a wide range of storage material is further supported by the 
genotype-dependent spectral differences observed in Cln3KI/KI microglia, which 
displayed increased fluorescence intensity in select channel wavelengths, likely 
reflecting the specific accumulation of ceroid and not all possible subtypes of 
autofluorescence-emitting storage materials that may accumulate in AF+ microglia 
with normal aging.  
One limitation of this study is that the identification of AF subsets currently 
requires analysis of a single cell suspension by flow cytometry. Efforts leveraging 




distribution in situ of AF+ and AF- microglia in the context of different CNS regions and 
in relation to other cell types or subcellular structures such as synapses or apoptotic 
bodies. Understanding how aging and lysosomal dysfunction modify the spatial 
distribution of these two microglia subsets within the CNS should ultimately improve 
our understanding of the differential origin and composition of storage bodies 
accumulating in AF+ microglia.  
When imaged by TEM, several types of storage compartments were detected 
in AF+ microglia, among which were: lipid-based storage material which was 
reminiscent of the lipid droplets recently described in lipid droplet-accumulating 
microglia (LDAM) (Marschallinger et al., 2020); crystalline deposits which resembled 
cholesterol crystals previously described in foamy macrophages, lipid laden 
microglia and endothelial cells (Tangirala et al., 1994; Klinkner et al., 1995; Cantuti-
Castelvetri et al., 2018; Baumer et al., 2017); and finally, curvilinear and fingerprint-
like pattern depositions, which are hallmark features of storage disorders such as 
NCL and progranulin haploinsufficiency (Cotman et al., 2002; Anderson et al., 2006; 
Ward et al., 2017b) and suggested a mechanistic convergence between 
lipofuscinosis/ceroid pathologies and microglia dysfunction associated with aging 
(Spittau, 2017).  
In addition to differences in subcellular content and population dynamics, AF+ 
microglia showed distinct differences at the proteome level, characterized by 
increased representation of endolysosomal and autophagic pathways as well as 




b-oxidation. These proteomic differences are reminiscent of previously reported 
effects of aging on the microglia proteome, which consisted of a bioenergetic shift 
towards fatty-acid utilization, perturbations in the regulation of gene expression and 
an upregulation of proteins suggestive of mitochondrial dysfunction (Flowers et al., 
2017). However, while those changes were observed in microglia from 24-month old 
mice, we detected these differences in AF+ microglia from mice as young as 12-month 
old, suggesting that this aging signature may be primarily driven by the AF+ subset. 
GO term enrichment and IPA analyses also identified dysregulation of mTOR-related 
proteins and pathways in AF+ microglia. mTORC1, which integrates upstream 
pathways sensing nutrient availability, cellular energy and growth factors, regulates 
cell growth through its control of metabolism, autophagy, protein translation and 
organelle biogenesis (Liu & Sabatini, 2020). The activity of mTORC1 is tightly 
controlled by its recruitment to the lysosomal surface by the Rag-Ragulator complex, 
where is it brought into close proximity to the activating GTPase Rheb. The elevated 
levels of Ragulator components (LAMTOR1, 2, 4, 5) and Rag members RRAGA/B and 
RRAGC in AF+ cells are likely reflective of the increased lysosomal content present in 
these cells. The oxidative and catabolic metabolic profile of AF+ microglia along with 
their overrepresentation of autophagic proteins points to an impaired activation of 
mTOR in AF+ microglia and suggests that pharmacological modulation of mTOR may 
restore AF+ microglia physiology, a hypothesis that remains to be tested. Intriguingly, 
recent work exploring the effects of elevated mTORC1 signaling in Tsc1-deficient 




coincident with decreased synaptic density and a more reactive microglial 
morphology (Zhao et al., 2018).  
 In prior studies which analyzed lipofuscin in microglia during aging (Mendes-
Jorge et al., 2009; Nakanishi & Wu, 2009; Moreno-García et al., 2018), the assumption 
was that the accumulation occurred equivalently across all microglial cells. Instead, 
we have established that the progressive increase of AF material and associated 
accumulation of LAMP1+ storage bodies are occurring exclusively within AF+ 
microglia, highly suggestive of functional differences between subsets. In contrast, 
AF– microglia remained devoid of AF signal during natural aging and even when 
lysosomal function was impaired by the Cln3∆ex7-8 mutation. The persistence of the 
AF– subset in those perturbed conditions suggests specific mechanisms or regional 
cues governing the distinct functions unique to each AF subset that will be the object 
of future investigation. Interestingly, aging-related myelin degradation, shedding and 
subsequent phagocytosis by microglia were proposed to be the primary contributors 
to the accumulation of lipofuscin (Safaiyan et al., 2016). However, our observations 
in the MBP-mutant Shiverer mice (Molineaux et al., 1986), which exhibit CNS 
hypomyelination and myelin sheath instability (Bird, Farrell & Sumi, 1978; Privat et 
al., 1979; Kirschner & Ganser, 1980; Safaiyan et al., 2016; Weil et al., 2016), do not 
fully support this model as the bimodal AF distribution was largely unaltered in 
Mbpshi/shi microglia despite their upregulation of CLEC7A/DECTIN1, which likely 
reflected  their active phagocytosis of apoptotic bodies and cellular debris caused by 




the primary contributor to the microglia AF signal.  This conclusion is compatible with 
observations made in the subretinal layers of the eye where the increased lipofuscin 
signal observed in microglia with aging or age-related macular degeneration was not 
linked to myelin phagocytosis, but to the phagocytosis of rod outer segments and 
apoptotic retinal pigment epithelial cells (Xu et al., 2008; Santos et al., 2010).  
While the lack of alterations in AF with the loss of Fc-receptor- or TREM2-
mediated phagocytosis indicates that those particular pathways are not key 
contributors, AF accumulation may still be impacted by alternative phagocytic 
pathways active in microglia that were not tested in this study, such as TAM (Tyro3, 
Axl, Mer) (Fourgeaud et al., 2016; Tufail et al., 2017), SIRPα-CD47 (Hutter et al., 2019) 
and C3-CD11b (Fu et al., 2012; Schafer et al., 2012). In contrast, we established that 
lysosomal and autophagosomal degradation pathways are primary mechanisms of 
accumulation of AF material, as evidenced by the accelerated and decreased AF 
accumulation respectively observed in AF+ microglia from Cln3∆ex7-8 mice and Atg5-
deficient microglia. Of all cell types in the brain, microglia express the highest 
transcript levels of Cln3, which is involved in the regulation of lysosomal pH, 
cathepsin activity, and endocytic trafficking (Cárcel-Trullols, Kovács & Pearce, 2017; 
Cotman & Staropoli, 2012; Golabek et al., 2000; Schmidtke et al., 2019). Although the 
disruption of Cln3 expression was present in both AF+ and AF– cells in Cln3∆ex7-8 mice, 
the latter subset was unaffected by the perturbation of the lysosomal pathway, 




microglia, which further highlights the molecular differences between AF+ and AF- 
microglia.  
While lipofuscin accumulation has been linked to age-related neuronal and 
microglial functional decline (Brunk & Terman, 2002; Jung, Bader & Grune, 2007; 
Sierra et al., 2007; Kurz et al., 2008; Höhn & Grune, 2013; Bernhardi, Eugenín-von 
Bernhardi & Eugenín, 2015; Safaiyan et al., 2016), the ability to precisely characterize 
its functional impact was impeded by the inability to isolate microglia which 
accumulated AF storage material from those which did not. Here, we overcame this 
limitation by developing a method permitting the isolation of these microglia subsets 
and established that the age-dependent accumulation of AF storage material was 
associated with increased mitochondrial mass and ROS production, decreased 
homeostatic proliferation and increased cell death rates in AF+ cells. Increased ROS 
production by aging AF+ microglia could be a direct consequence of the accumulation 
of AF material as lipofuscin can incorporate transition metals such as copper and iron, 
which form a redox-active surface catalyzing the Fenton reaction and promote 
mitochondria-independent cytotoxic effects (Höhn et al., 2010). Alternatively, the 
increased generation of ROS in AF+ could result from mitochondrial dysfunction, a 
pathway enriched in the AF+ proteome, or from the highly catabolic metabolism of 
AF+ cells and their reliance on fatty acid β-oxidation, which is another major a source 
of ROS. 
 In addition to ROS, the accumulation of undegraded macromolecules within 




(Lamanna et al., 2011; Prinetti et al., 2011; Walkley & Vanier, 2009), could further 
propel the lysosomal system into complete dysfunction. The subsequent 
overaccumulation of storage material may also physically damage the lysosomal 
membranes, causing dispersal of storage contents into the cytosol or the extracellular 
space and subsequent inflammasome activation and neuronal cell death, as it was 
shown recently in a genetic model for acid sphingomyelinase deficiency and in a 
demyelination model (Cantuti-Castelvetri et al., 2018; Gabandé Rodríguez et al., 
2018). Foam cell macrophages, which are generated by the overaccumulation of 
oxidized low-density lipid protein and cholesterol in atherosclerotic plaques, have 
been shown to contribute to vascular pathology via these precise mechanisms 
(Duewell et al., 2010; Childs et al., 2016; Hakala et al., 2003; Gibson, Domingues & 
Vieira, 2018). Interestingly, foam cell macrophages exhibit many of the 
ultrastructural features observed in aged AF+ microglia and thus may share common 
pathways precipitating cellular dysfunction and tissue pathology. Lastly, another 
possible mechanism by which AF material could trigger microglia dysfunction and 
cytotoxic effects is via its binding and inhibition of the proteasome and the associated 
perturbation of cellular proteolytic functions, as it was previously reported for 
lipofuscin (Szweda et al., 2003; Höhn et al., 2011; Sitte, 2000).  
Despite the striking stability of the AF subset ratio throughout most adult 
mice, cumulative and age-dependent AF accumulation ultimately resulted in the 
collapse of the ratio of AF+ to AF– microglia in advanced aging, likely due to one of the 




microglia from Cln3ex7-8 mice phenocopied the effect of advanced aging on microglia 
by selectively increasing apoptotic rates of AF+ cells and resulting in an early and 
precipitous decline of the AF+ subset. Altogether, these results suggest a convergence 
of mechanisms operating during aging and in lysosomal storage disorders whereby 
the accumulation of storage bodies in AF+ cells drives microglia dysfunction, possibly 
contributing to neurodegeneration known to be associated with both conditions.  
Together, these results provide novel insight into microglia physiology by 
identifying two previously unknown subsets which exist at steady state in the murine 
and non-human primate CNS. The ability to identify and isolate distinct microglia 
subsets via a cell-intrinsic, label-free method presents future opportunities to further 
characterize any additional functions that may shed light on their subset-specific 
roles in maintaining the delicate balance between CNS homeostasis and 
neurodegeneration. The significance of these subsets is clearly highlighted by a model 
of juvenile neuronal ceroid lipofuscinosis in which lysosomal dysfunction was born 
solely by AF+ microglia, whereas AF– microglia appeared unaffected. Lastly, the 
finding that the progressive depletion of AF+ microglia occurred as function of natural 
brain aging raises the possibility that this subset may be functionally protective and 






Figure 17: Working model for the generation and maintenance of AF subsets.  
Cellular autofluorescence identifies unique subsets of microglia. AF+ microglia progressively 
accumulate autofluorescent material through ingestion of extracellular debris and synapses. 
This accumulation of AF can be accelerated through targeted genetic disruption of 
lysosomal function. As AF+ microglia progressively accumulate autofluorescence material, 
their cellular functions decline and they exhibit increased ROS production, mTORC1 
activation and apoptosis. AF– microglia specifically replenish AF+ microglia lost via 





CHAPTER FOUR: METHODS 





















NHP brain samples Charles River Labs   
freshly isolated 
same day 
other DAPI ThermoFisher Cat# 62248 concentration of 0.1 ug/mL 
antibody anti-mouse CD11b BV510 (rat monoclonal) Biolegend RRID:AB_2561390 FlowCyt (1:200) 
antibody anti-mouse CD45 BV785 (rat monoclonal) Biolegend RRID:AB_2564590 FlowCyt (1:200) 
antibody anti-mouse CX3CR1 BV421 (rat monoclonal) Biolegend RRID:AB_2565706 FlowCyt (1:200) 
antibody anti-mouse P2RY12 PE (rat monoclonal) Biolegend RRID:AB_2721644 FlowCyt (1:200) 





Biolegend RRID:AB_2563203 FlowCyt (1:400) 
other AnnexinV AlexaFluor647 ThermoFisher Cat# A23204  Apoptotic cell labeling reagent 





Biolegend RRID:AB_571990 FlowCyt (1:200) 
antibody anti-mouse KI-67 BV421 (rat monoclonal) Biolegend RRID:AB_2629748 FlowCyt (1:100) 
antibody anti-mouse Ly6G PE (rat monoclonal) 
BD 
Biosciences RRID:AB_394208 FlowCyt (1:100) 




antibody anti-mouse CD3 PE (rat monoclonal) 
BD 
Biosciences RRID:AB_395699 FlowCyt (1:100) 
antibody anti-mouse CD19 PE (rat monoclonal) 
BD 
Biosciences RRID:AB_395050 FlowCyt (1:100) 
antibody anti-mouse NK1.1 PE (rat monoclonal) 
BD 
Biosciences RRID:AB_396674 FlowCyt (1:100) 
antibody anti-mouse CD45 AF488 (rat monoclonal) Biolegend RRID:AB_493531 FlowCyt (1:100) 
antibody anti-mouse CX3CR1 BV785 (rat monoclonal) Biolegend RRID:AB_2565938 FlowCyt (1:200) 
antibody anti-mouse CD11b APC (rat monoclonal) Biolegend RRID:AB_312794 FlowCyt (1:200) 






































Trem2-/- KOMP repository 
RRID:MMRRC_05020




Mbpshi Jackson Laboratory  
RRID:IMSR_JAX:0014









algorithm FlowJo V10 TreeStar RRID:SCR_008520   
software, 
algorithm Prism 8.0 Graphpad RRID:SCR_002798   
software, 




1.6.0.16 Max Planck RRID:SCR_014485   
software, 








other Percoll GE Healthcare Cat# 17-0891-01 
 Medium for 
density gradient 
centrifugation 
other Mitotracker DeepRedFM ThermoFisher Cat# M22426 
Mitochondrial 
fluorescent dye, 
used at 50 nM 
other CellROX DeepRed ThermoFisher Cat# C10491 
ROS fluorescent 
detection agent, 











assay or kit RNEasy Plus Micro Qiagen Cat# 74034   
commercial 





control primers, M. 
musculus 
ThermoFisher Cat# 4352339E   
commercial 
assay or kit QuantiTect Multiplex PCR  Qiagen Cat# 204541   
software, 
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This study was performed in accordance with the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals. Research animals at Biogen were housed 
under specific pathogen free conditions in an AAALAC accredited facility with a 12h - 
12 h light - dark cycle and environmental conditions controlled at 21°C and 40-60 % 
humidity. Animals handled according to an approved institutional animal care and 
use committee (IACUC) protocol (#756). This study was reviewed and approved by 
the Massachusetts General Hospital (MGH) Subcommittee of Research Animal Care 
(SRAC), which serves as the Institutional Animal Care and Use Committee (IACUC) for 
MGH (Protocol #2008N000013). C57BL/6J, B6.129P2-Apoetm1Unc/J, C3Fe.SWV-
Mbpshi/J(Chernoff, 1981), B6J.B6N(Cg)-Cx3cr1tm1.1(cre)Jung/J (Cx3cr1CreERT2) (Yona et al., 
2013) were purchased from Jackson Labs. B6.129S-Atg5<tm1Myok> (Atg5flox) (Hara et 
al., 2006) were acquired from Dr. Noboru Mizushima (University of Tokyo). 
Cln3ex7/ex8 knock-in mice (Cotman et al., 2002) were generously provided by Dr. 
Susan Cotman (Harvard Medical School) and carry a  ~1kb genomic deletion in the 
lysosomal gene Cln3 that is orthologous to the commonly observed mutation in 
Juvenile Neuronal Ceroid Lipofuscinosis patients. This exonic deletion results in the 
production of an alternatively spliced mRNA species encoding a detectable non-
truncated CLN3 mutant protein. B6.129P2-Fcer1gtm1Rav N12 (Fcer1g/)(Takai et al., 
1994)were purchased from Taconic. Trem2tm1(KOMP)Vlcg (Trem2/) were acquired 
from the KOMP repository. Atg5/ mice were generated by crossing the Atg5flox and 
Cx3cr1CreERT2 lines. Age-matched cohorts were used in all experiments. All mice used 







One gram of tamoxifen (Cat# T5648, Millipore-Sigma) was dissolved in 5 mL ethanol 
and then mixed with 45 mL of corn oil USP (Cat# CO136, Spectrum Chemical) warmed 
at 37C for a final concentration of 20 mg/mL. 6-week old mice were given two 200 
μL subcutaneous injections of tamoxifen-corn oil, spaced 48 hours apart to induce 
genetic recombination.  
Isolation of murine microglia for flow cytometry 
All solutions were used ice-cold unless otherwise noted. Immediately following CO2 
euthanasia, mice were transcardially perfused with 20 mL of phosphate buffered 
saline (PBS) containing 3 mM EDTA. Brains were dissected and transferred into a 15 
mL conical tube filled with Hanks’ Balanced Salt Solution (HBSS) on ice. For tissue 
homogenization, brains were transferred to a Petri dish and minced over ice with a 
scalpel. Minced tissue was transferred to a 7 mL glass dounce homogenizer (Cat# 
57542, Wheaton) containing 5 mL of HBSS + 25 mM HEPES and homogenized with a 
pestle for approximately 10 strokes each. The single cell suspension was transferred 
to a 15 mL conical tube and centrifuged at 300xg for 5 minutes at 4C. The 
supernatant was aspirated, and the cell pellet was gently resuspended in 1 mL of fetal 
bovine serum (FBS). A 33% isotonic Percoll solution was prepared by combining 9 
mL of Percoll (Cat# 17-0891-01, GE Healthcare) with 1 mL of 10X HBSS and 20 mL of 
1X HBSS + 25 mM HEPES. 9mL of the 33% isotonic Percoll solution was then added 
and the cell suspension mixed by inversion. 1 mL of a 10% FBS/HBSS solution was 
overlaid on the Percoll suspension and the cells were centrifuged at 800g for 15 
minutes at 4C with no brake. The resulting cell pellet was washed once in 10mL 
HBSS + 25 mM HEPES, centrifuged at 300xg for 5 minutes at 4C and resuspended in 
a final volume of 1mL HBSS + 25 mM HEPES. Antibody staining was performed in a 
96 well v-bottom plate (Cat# 3897, Corning) with the following antibodies after Fc-




BV785 (clone 30-F11, BioLegend), anti-CD11B BV510 (clone M1/70, BioLegend), 
anti-CX3CR1 BV421 (clone SA011F11, BioLegend), and anti-P2RY12 PE (clone 
S16007D, BioLegend). For unconjugated anti-TMEM119 (clone 101-6, Abcam) an 
anti-rabbit AlexaFluor488 secondary antibody (clone Poly4064, BioLegend) was 
used. DAPI (Cat# 62248, ThermoFisher Scientific) was used to assess viability. For 
apoptotic cell analysis, AnnexinV conjugated to AlexaFluor647 (Cat# A23204 
ThermoFisher Scientific) was used according to the supplier protocol after surface 
staining.  For intracellular antigens, cell suspensions were fixed and permeabilized 
using the Transcription Factor Staining kit (Cat# 00-5523-00, ThermoFisher 
Scientific) after surface staining with ZombieUV Fixable Viability dye (Cat# 423107 
BioLegend). Fixation was followed by staining with CD68 FITC (clone FA11, 
BioLegend) LAMP1 AlexaFluor647 (clone 1D4B, BioLegend) and KI-67 BV421 (clone 
11F6, BioLegend). Absolute cell counts were determined using 123count eBeads 
(Cat# 01-1234-42, ThermoFisher Scientific) Flow cytometry data were acquired on a 
5 laser-equipped LSRFortessa X-20 (BD Biosciences) and analyzed in FlowJoV10 
(Treestar). Non-autofluorescent peripheral immune cells were used as negative 
controls to determine the initial bifurcating gate to identify AF– and AF+ microglia 
subsets. To subdivide the AF+ subset, a gate encompassing AFhi microglia was drawn 
to capture the AF+ gaussian peak. The AFdim gate was drawn between the edge of the 
AF– population and the base of the AF+ gaussian peak (lower boundary of AFhi gate).    
Imaging flow cytometry data were acquired with an AMNIS Imagestream MKII 
(Millipore-Sigma) and analyzed with AMNIS IDEAS software.  
Isolation of non-human primate microglia for flow cytometry 
Immediately following euthanasia, Cynomolgus macaques were transcardially 
perfused with an ice-cold Lactated Ringers Solution (LRS). Brains were removed and 
placed into ice-cold LRS and kept chilled until processing. Approximately 500 mg of 
tissue from the frontal cortex was excised, minced and gently homogenized on ice in 




25 mM HEPES. Microglia were then isolated using the same procedure as described 
above for murine microglia. Antibody staining was performed in a 96 well v-bottom 
plate (Cat# 3897, Corning) with the following antibodies after Fc-receptor blocking 
(Human TruStain FcX, Cat#422301, Biolegend): anti-CD45 BV786 (clone D058-1283, 
BD Biosciences), anti-CD11B BV510 (clone ICRF44, BD Biosciences).  
 
Isolation of murine microglia for fluorescence activated cell sorting (FACS) 
Single cell suspensions were prepared as previously described for flow cytometry 
microglia isolations through the initial centrifugation. The resulting cell pellet was 
resuspended in 5 mL of a room-temperature (RT) 70% isotonic Percoll solution, 
which was carefully overlaid with 5 mL of a 37% RT isotonic Percoll solution. The 
Percoll cell suspension was then centrifuged at 800g for 25 minutes at 22C with 
acceleration set to 50% and brake set to 10%. Enriched microglia were then carefully 
collected from the 37%/70% Percoll interphase to a new 15 mL conical tube 
previously blocked with 2% bovine serum albumin (BSA) in PBS at RT for 3 hours. 
Microglia were washed once with 10 mL of ice-cold HBSS + 25 mM HEPES and 
centrifuged at 300g for 5 minutes at 4°C. The resulting microglia cell pellet was 
resuspended in 100 μL of HBSS + 2% BSA. Cell suspensions were Fc-blocked and then 
stained with anti-CD45 AF488 (clone 30-F11, BioLegend), anti-CD11B APC (clone 
M1/70, BioLegend), anti-CX3CR1 BV785 (clone SA011F11, BioLegend). DAPI was 
used for viability and a dump gate in the PE channel was created with the following 
antibodies: anti-Ly6G PE (clone 1A8, BD Biosciences), anti-Ly6C PE (clone HK1.4, 
BioLegend), anti-CD3 PE (clone 17A2, BD Biosciences), anti-CD19 PE (clone 1D3, BD 
Biosciences), anti-NK1.1 PE (clone PK136, BD Biosciences). Cell sorting was 




Proteomics Sample Preparation and Data Acquisition 
75,000 microglia were FACS-isolated into tubes containing the dried residual of 150 
μL 8M urea, 5 mM EDTA, 0.1M Tris/HCl pH 8.5, resulting in final volumes of 300 μL. 
The suspensions were mixed and stored frozen until used. Lysates were thawed and 
treated with a E220 focused beam ultrasonicator (Covaris) 20 times at 2 s each with 
150W output. Lysates were clarified by centrifugation, reduced with 10 mM final 
concentration of DTT for 20 min and subsequently alkylated with 30 mM 2-
iodoacetamide for 30 min at room temperature. After a two-fold dilution in water, 
samples were digested overnight with 0.05 μg LysC (Wako) and 0.2 μg modified 
trypsin (Promega). Peptides were acidified to a final concentration 0.5% (v/v) 
trifluoroacetic acid and desalted using C18 StageTips (Rappsilber, Mann & Ishihama, 
2007). 50% of resulting peptides were separated on a 50 cm, 75 μm inner diameter 
EasySpray column packed with 2 μm PepMap C18 RSLC material (ThermoFisher) 
over 120 min using an EASY-nLC 1200 system (ThermoFisher). Peptides were 
analyzed online with an Orbitrap Fusion-Lumos mass spectrometer (ThermoFisher) 
in data-dependent acquisition mode. Full scans were acquired at a resolution of 
240,000 in the Orbitrap analyzer and the most abundant precursors were selected in 
a 1 s scan cycle for higher-energy dissociation (HCD) with a 0.7 Th isolation window, 
a target of 10,000 ions and a maximum injection time of 25 ms, followed by detection 
fragment ion in the ion trap. 
Proteomics Data Analysis 
Raw data were processed in MaxQuant Version 1.6.0.16 (Cox & Mann, 2008) and 
searched with Andromeda (Cox et al., 2011) against a comprehensive SwissProt 
release for mouse with a false discovery rate of 1% at the peptide and protein level. 
Identifications of MS1 features were transferred between samples using the Match 
Between Runs option with a 0.2 min matching tolerance. Label-free protein 




analysis was performed in Perseus (Tyanova et al., 2016). After log transformation 
and applying a filter for proteins quantified in at least 50% of samples in either group, 
missing values were imputed with a normal distribution with a mean shifted down 
by 1.8-fold and a width of 0.3-fold in relation to the standard distribution of measured 
values of the respective sample. p values were calculated using Student’s t-test and 
the false discovery rate was controlled with the Benjamini-Hochberg method. 
Proteins were determined to be differentially expressed if they met an adjusted p 
value threshold of < 0.01 and an absolute fold change difference threshold of > 1.3. 
Human orthologs of identified mouse proteins were assigned using Panther and GO 
term enrichment of differentially expressed proteins was calculated with the Panther 
Overpresentation Test (Mi et al., 2019). Canonical pathway analysis and identification 
of upstream regulators was performed with Ingenuity Pathway Analysis (Qiagen). 
Transmission electron microscopy 
Microglia from pooled animals (n = 10 per age) were FACS-isolated directly into tubes 
containing 4% glutaraldehyde/0.1M sodium-cacodylate solution, pH 7.4 (Electron 
Microscopy Sciences, Hatfield, PA). Fixed cells were pelleted and post-fixed in 1.0% 
osmium tetroxide in cacodylate buffer for 1 hour at RT, rinsed in cacodylate buffer, 
and stabilized using 2% agarose in PBS. Agarose-embedded pellets were dehydrated 
through a graded series of ethanols to 100%, then dehydrated briefly in 100% 
propylene oxide. Specimens were infiltrated in a mix of 2:1 propylene oxide/Eponate 
resin (Ted Pella, Redding, CA) 2 hours at room temperature on a gentle rotator, then 
switched into a 1:1 mix of propylene oxide/Eponate resin and allowed to infiltrate 
overnight on a gentle rotator. 24 hours later, specimens were placed into fresh 100% 
Eponate resin and allowed to infiltrate for several hours, then embedded in flat molds 
with fresh 100% Eponate. Polymerization occurred within 24-48 hours at 60°C. Thin 
(70 nm) sections were cut using a Leica EM UC7 ultramicrotome, collected onto 
formvar-coated grids, contrast-stained with uranyl acetate and Reynold's lead citrate 




were collected using an AMT digital imaging system with proprietary image capture 
software (Advanced Microscopy Techniques, Danvers, MA). TEM image analysis and 
area determinations for subcellular features were calculated in FIJI (Schindelin et al., 
2012). Cytosolic area values were calculated by determining the full cellular area and 
subtracting the nuclear region. 
Mitochondrial content 
Mitotracker DeepRedFM (Cat# M22426, ThermoFisher Scientific) reagent was used 
according to the supplier protocol. Briefly, a single cell suspension of isolated 
microglia was surface stained with CD45 BV786 and CD11B BV510. Cells were 
pelleted and then resuspended gently in 500 L prewarmed 37°C staining solution 
containing 50 nM of Mitotracker reagent. Cells were incubated for 30 minutes at 37°C 
in a humidified 5% CO2 incubator then pelleted and resuspended in 200 L of 
HBSS+2% BSA for analysis by flow cytometry.  
ROS detection 
CellROX Deep Red (Cat# C10491, ThermoFisher Scientific) was used according to 
supplier protocol. Briefly, a single cell suspension of isolated microglia was surface 
stained with CD45 BV786 and CD11B BV510. Cells were pelleted and then 
resuspended gently in prewarmed RPMI1640 (Cat# 11875085, ThermoFisher 
Scientific) containing 10% FBS. Cells were treated with a 100 M solution containing 
tert-butyl hydroperoxide for 30 minutes at 37°C in a humidified 5% CO2 incubator to 
induce ROS. CellROX reagent was then added to a final concentration of 500 nM and 
the cells were incubated for 45 minutes at 37°C. Cells were pelleted, resuspended in 
200 L of prewarmed RPMI1640/10%FBS containing DAPI (0.1 g/mL final 





To deplete microglia, 14-month old mice were orally treated q.d. for 7 days with 
BLZ945 at a dose of 200 mg/kg body-weight (Krauser et al., 2014) in a 20% captisol 
solution. Vehicle-treated mice received only 20% captisol solution. Tissues were 
collected at the indicated time after last dose.  
RNA isolation and quantitative real-time PCR 
50,000-100,000 microglia were FACS-isolated directly into chilled RNA/DNA free 
microfuge tubes containing 500L RLT-plus lysis buffer supplemented with 1% 2-
mercaptoethanol. RNA was isolated with the RNEasy Plus Micro Kit (Cat# 74034, 
Qiagen) according to the kit protocol. RNA quality was assessed using the Agilent 
RNA6000 Pico kit (Cat# 5067-1513, Agilent) on an Agilent Bioanalyzer system. RNA 
quantity was determined with the Quant-iT RiboGreen Fluorescence assay (Cat# 
R11490, ThermoFisher Scientific). Isolated RNA was then converted to cDNA using 
the SuperScript IV VILO kit (Cat# 11754050, ThermoFisher Scientific) per 
manufacturer protocol. Microglia cDNA was combined with a QuantiTect Multiplex 
PCR (Cat# 204541 Qiagen) master mix containing Taqman primers spanning Atg5 
exons 3-4 (AssayID Mm01187301_m1, Cat# 4351372, ThermoFisher Scientific) and 
Gapdh endogenous control primers (Cat# 4352339E, ThermoFisher Scientific). qRT-
PCR reaction was run for 40 cycles on a QuantStudio12K Flex instrument 
(ThermoFisher Scientific) and relative quantity (RQ) of Atg5 transcript was 
calculated using the 2Ct method. 
Statistical analysis 
Statistical analysis was performed using Prism software (GraphPad, San Diego, CA). 
To determine significance values when comparing AF subsets, a paired, two-tailed t-
test or 2-way repeated measures ANOVA with Tukey’s or Sidak’s post-hoc multiple 
comparison’s test were utilized. For comparisons between genotypes, significance 




by Tukey’s post-hoc for multiple comparisons. For BLZ945 experiments, a 1-way 
ANOVA followed by Dunnett’s post-hoc test for multiple comparisons was used. A 
value of p < 0.05 was considered statistically significant. All data were presented as 
the mean with standard deviation.  
Data Availability 
Data are available via ProteomeXchange. 
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